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Iodide is a well known halogen necessary for development. The majority of 
iodide processing in biological systems occurs in the thyroid gland. Iodide salvage is 
essential to thyroid hormone metabolism and metabolic regulation. The DEHAL1 
gene product iodotyrosine deiodinase (IYD) is responsible for deiodination of the 
mono- and diiodotyrosine byproducts of thyroid hormone synthesis (triiodothyronine 
and thyroxine, T3 and T4, respectively). IYD is a membrane-bound flavoprotein 
comprised of three domains with the catalytic domain belonging to the NADPH 
oxidase/flavin reductase structural superfamily.  This enzyme required engineering 
for expression of soluble protein in E. coli and was characterized using CD spectra, 
kinetic rate constants, binding constants of substrates, and crystal structure.  Analysis 
  
of the crystal structure of IYD indicates a dimer with an active site comprising of 
both monomers and orienting the C-I bond of iodotyrosine substrate stacking above 
the N5 of the flavin mononucleotide (FMN) required for activity.  The crystal 
structure also identifies an active site lid that distinguishes IYD from other proteins in 
the NADPH oxidase/flavin reductase superfamily. Three amino acids (E153, Y157, 
and K178) on the active site lid form hydrogen bonding and electrostatic contacts 
with the zwitterionic portion of the substrate.  Mutation to any of these three amino 
acids significantly decreases substrate-binding affinity and enzymatic activity. 
Homologous sequences of IYD were identified in other organisms and four sequences 
as representatives from their phyla were expressed in E. coli. Zebrafish, lancelets, 
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Chapter 1: Introduction 
1.1 Iodide Salvage 
Iodide is a critical micronutrient for mammalian health, and deficiencies in 
either dietary iodide or iodide metabolism may lead to hypothyroidism, goiter, and 
developmental defects. The World Health Organization has identified iodide 
deficiency as a leading cause of impaired cognitive development in children resulting 
in a drop of approximately 15 IQ points (1). Over a billion people worldwide are 
estimated to lack sufficient access to iodide despite the modest requirement for this 
micronutrient (recommended daily allowance of 150 µg) (1).  Iodide is quite scarce in 
land-locked environments. However, even seawater has a very low concentration of 
iodide (under 1 µM), which is well below that of the other halogens (2). In seawater, 
brown algae, a major food in marine diets, accumulates iodide (3).  
Iodide is utilized by the thyroid to synthesize the thyroid hormone 3,3’,5-
triiodothyronine (T3) and its precursor 3,3’,5,5’-tetraiodothyronine (T4) (Figure 1.1). 
Almost a century ago, the thyroid was determined to be essential for development and 
metamorphosis. Endogenous thyroid hormone metabolism has been extensively 
studied beginning as far back as the 1920s. Removal of thyroids in amphibian 
cultures does not result in metamorphosis. However, injecting thyroid particulates or 
iodotyrosines (mono- or diiodotyrosine, MIT or DIT, respectively) did allow for 
metamorphosis in amphibians (4). Here, MIT and DIT serve as the iodide source for 
the organisms. Interestingly, in the same study, larvae that were fed bromotyrosines 
showed no change in anatomic transformations. This indicates that bromide cannot be 




studies in lancelets, the most basal chordates, identified thyroid hormone receptors 
that bind thyroid hormone derivatives (5). Chordates utilize thyroid hormones in 
conjunction with their respective receptors to regulate metamorphosis (6, 7). The 
process of metamorphosis and its key players are conserved through chordate lineage. 
 
Figure 1.1 Monoiodotyrosine and diiodotyrosine are the by-products formed during 
T3 and T4 biosynthesis.  
 
The Chordate thyroid gland emerged through evolution. Vertebrates have a 
specific follicular thyroid gland to gather iodide and produce thyroid hormones. 
Cephalochordata and Urochordata have a region of their body, identified as an 
endostyle, that functions as a thyroid (8). More primitive organisms, such as sand 
dollars (Peronella japonica), do not have a defined region but do have indications of 
a use for thyroid hormones, specifically in metamorphosis (9).  Thyroid function can 
be traced back as far as Cyanobacteria in its ability to use iodide as an antioxidant 
(10). As organisms developed and transferred from the relatively iodide-rich water 




iodide. This adaptation is evidenced by an iodide reserve in the thyroid gland. Iodide 
in the vertebrate thyroid is used to produce iodinated thyroid hormones.  
The production of thyroid hormones is very well characterized in mammalian 
systems. First, the sodium iodide symporter (NIS) transports iodide into the thyroid 
cells (Figure 1.2). NIS, located in the basal membrane of thyroid follicular cells, 
concentrates iodide (40-fold) from the plasma (11). Iodide is then transported into the 
colloid where iodination of tyrosine residues on thyroglobulin occurs via thyroid 
peroxidase. Thyroglobulin is the major constituent of the thyroid colloid and its 
mono- and diiodinated tyrosine residues serve as intermediates in the formation of T3 
and T4. Approximately a quarter of the ~220 tyrosine residues found in thyroglobulin 
are available for iodination.  Some of the proximal iodinated tyrosines undergo a 
peroxidase-mediated conjugation to form T4. Ultimately, each thyroglobulin 
polypeptide produces one T4, while seven MITs and six DITs remain and just one out 
of every three thyroglobulin polypeptides produces one T3 rather than T4 (12). 
Thyroid stimulating hormone initiates endocytosis of thyroglobulin into the follicular 
thyroid cells. Subsequent proteolysis of thyroglobulin releases T3 and T4, as well as 





Figure 1.2 Iodide uptake, transport, metabolism and salvage in follicular thyroid cells. 
Adapted from (13). 
 
 
Iodide in the thyroid is stored as iodinated tyrosine residues of thyroglobulin. 
Upon proteolysis, these amino acids are released from the protein as waste. 
Reincorporation of iodide into thyroglobulin requires free iodide rather than iodinated 
tyrosines. MIT and DIT released during proteolysis of thyroglobulin are deiodinated 
by iodotyrosine deiodinase (IYD) (Figure 1.3). This recycling is critical for thyroid 
hormone production; otherwise, MIT and DIT would be excreted as waste, 





Figure 1.3 IYD catalyzes the deiodination of MIT and DIT. 
 
1.2 Cysteines and deiodination 
 Iodothyronine deiodinases (ID) catalyze the reductive deiodination of thyroid 
hormones T3 and T4 and their derivatives (15).  T3 is 10-fold more potent for 
regulating metabolism than T4 (15), and therefore the enzyme that catalyzes this 
reaction (ID) is biologically relevant.  ID contains an essential active site 
selenocysteine, which is involved in catalysis. Mutation of this selenocysteine to 
cysteine reduces the catalytic activity of ID by 100-fold (15). The net reaction 
promoted by ID relies on the reducing power of thiols to regenerate its active site 
selenocysteine from a proposed selenyl iodide reaction (16).  
IYD was originally thought to deiodinate its substrate by a similar mechanism 
to ID (17). Mammalian IYD has two conserved cysteine residues that were thought to 
be responsible for catalysis (18).  A three-dimensional model of the catalytic domain 
predicted that the two cysteine nucleophiles were in close proximity to each other and 
FMN creating an active site (19). These two cysteines could react in a concerted 
fashion similar to the selenocysteines in ID. This theory was proven wrong when 
mutation of IYD’s two cysteines resulted in catalytically active protein (18). Single 




substrate turnover. This proved that cysteines are not responsible for removal of 
iodine from MIT or DIT. IYD must dehalogenate its substrate through a different 
reductive process.  
1.3 IYD is a dehalogenase 
There are three known reductive dehalogenation reactions in aerobic 
organisms, all of which are structurally independent. The first example, described 
above, is the deiodination of thyroid hormone by ID. This enzyme belongs to a 
thioredoxin superfamily that, unlike thioredoxin, has active site selenocysteines 
responsible for catalysis (20).  The second enzyme, tetrachlorohydroquinone 
dehalogenase, dechlorinates tetrachlorohydroquinone by nucleophilic attack of a 
cysteine through the oxidation of glutathione (21, 22). Tetrachlorohydroquinone 
dehalogenase is a member of the glutathione S-transferase structural superfamily. 
IYD has yet a third mechanism of action to promote dehalogenation; we already 
know that cysteines are not plausibly responsible. IYD is the only dehalogenase to 
utilize FMN (23, 24) and is a member of the NAD(P)H oxidase/flavin reductase 
structural superfamily (19). Turnover requires reduction of FMN by NADPH in vivo 
(25) and can be reduced in vitro by dithionite.  
IYD is the primary mechanism of iodide recycling in mammals (13). Recent 
advances in IYD expression and purification allowed for in depth investigation of 
enzymatic properties. Specifically, IYD was found to not only act as a deiodinase, but 
also as a much more versatile dehalogenase (26). Chlorinated and brominated 
tyrosine substrates were also found to have the same effect on the FMN spectrum 




FMN. However, the addition of fluorinated tyrosine to reduced IYD did not promote 
oxidation of FMN, and thus IYD does not have the catalytic power to reduce a C-F 
bond.  
Both chlorotyrosine and bromotyrosine are generated by peroxidases in vivo 
and used as markers for respiratory problems (27, 28).  IYD is not only found in the 
thyroid, but traces are found in other organs such as the kidney and liver (29). So it is 
possible that IYD can dehalogenate the halogenated tyrosines as they circulate 
thorugh the blood in either the liver or the kidney. Exposure to some brominated 
compounds has shown reduction of thyroid hormone concentrations (30). It is curious 
that IYD has the ability to complete these reactions while brominated tyrosines, 
unlike iodinated tyrosines, did not have a morphological effect on organisms as 
previously reported (4).   
 
1.4 IYD has unique function within its structural superfamily 
In its native state, IYD is a membrane bound protein that can be described in 
three structural domains (Figure 1.4). Its N-terminus binds the protein to the 
membrane, the C-terminus is the catalytic domain, and these two functional domains 
flank an intermediate domain with no known structure or function aside from 
connecting the two. The catalytic domain has been assigned to the NADPH 
oxidase/flavin reductase structural superfamily (19). Upon removal of the N-terminal 
membrane domain (residues 2-33), IYD retains activity albeit without its ability to be 
reduced by NADPH (18). Expression of the truncated protein in Sf9 cells produced 








Figure 1.4 IYD is comprised of three domains: a transmembrane domain (1-24), an 





IYD(Δtm), a transmembrane-deleted, soluble form, was crystallized with and 
without substrate present. It has a α-β fold that forms a domain-swapped dimer, which 
is characteristic of proteins in the superfamily (31) (Figure 1.5). The dimer interface 
is comprised of one helix from each monomer that forms an ‘X’ or a criss-cross at the 
boarder. The N- and C-terminal extensions from each polypeptide wrap around the 
opposite monomer, consistent within the NADPH oxidase/flavin reductase 
superfamily. Two equivalent active sites are comprised of amino acids from each 
polypeptide chain indicating that dimer formation is necessary for co-factor binding 
and catalytic activity. The co-crystals of IYD(Δtm)MIT contained two regions of 
electron density that were unavailable from IYD(Δtm). The new electron density 
implicates an active site lid that forms a helix-turn-helix covering the active site and 





Figure 1.5 An overview of the IYD homodimer crystallized in the presence of MIT 
substrate. Flavin is in yellow and MIT substrate is orange. 
 
 
Until recently, all proteins in the superfamily belonged to two sub-classes 
generally represented by NADH oxidase from Thermus thermophilus (32) and FRP 
from Vibrio harveyi (33).  The closest structural neighbor is BluB (PDB ID: 2ISK), a 
bacterial enzyme responsible for the degradation of its FMN cofactor (34). BluB and 
IYD differentiate themselves from the superfamily based on their differences in both 
structure and catalytic function. Specifically, IYD and BluB retain sequence that 
forms the active site lid in a region that does not share homology with the proteins in 
the other two classes of the superfamily (Figure 1.6).  For NOX, the lid is formed 
from a central region of its polypeptide. For FRP, the C-terminus is extended creating 






Figure 1.6 Secondary structure alignment of representatives of the NADPH 
oxidase/flavin reductase superfamily. IYD (PDB ID: 3FBD) and BluB (PDB ID: 
2ISL) now define a third subclass of the NADH oxidase/flavin reductase superfamily. 
NADH oxidase (NOX, PDB ID: 1NOX) and FRP (PDB ID: 2BKJ) illustrate the α-β 
fold for the original two subclasses of this superfamily. The boxed regions indicate 
the sequences that form the active site lids. The dotted lines indicate spacing inserted 




Despite the vast structural similarities (root mean square deviation of only 3.1 
Å), BluB and IYD only share 19% sequence identity and 43% sequence similarity. 
When we compare IYD to NOX or FRP having 42% sequence similarity of the 
crystallized domain (amino acids 66-273 of the mouse IYD sequence). This leads to 
questions of the relationship between sequence, structure, and function. The 
relationship between these has been elusive over the decades since protein structures 
were initially solved. In this superfamily, there is low sequence identity and high 
structure similarity. In general, protein sequence similarity/identity is equated to 
protein structure similarity. IYDs connection in this superfamily of bacterial enzymes 
leads to questions involving the evolution of the protein through animal lineage.  
 
 
1.5 Similarity of thyroidal enzymes in model organisms 
For years, less complex organisms have been extensively studied to model 




human diseases because of their availability, short life cycle, and commonalities in 
mammalian development. Many experiments that would be unethical to perform in 
humans are performed in mice.  Other organisms that are easier to maintain are used 
to study development including Caenorhabditis elegans (roundworms), Nematostella 
vectensis (sea anemone), and Strongylocentrotus purpuratus (sea urchin). A variety of 
organisms from different phyla have been used to study evolution including 
Branchiostoma floridae (lancelet), Drosophila melanogaster (fruit fly), and Danio 
rerio (zebrafish). 
Many of these organisms have evidence of thyroid hormone and homologous 
proteins to those found in the human thyroid. Specifically, the sodium iodide 
symporter, thyroid peroxidase, and thyroglobulin are all present in chordates. Thyroid 
hormone related proteins, including the transport protein transthryetin and activating 
enzyme iodothyronine deiodinase, are also thought to be present based on predicted 
proteins extrapolated from the genome. Some of the lower, less complex organisms 
that do not have a thyroid or thyroid-like gland, specifically species in the 
subphylums Echinodermata and Cnidaria, have both protein sequence that is 
homologous to IYD (57% identity) and an indication of thyroid hormones.  
Thyroidectomies were performed on amphibians to study the effect of lacking 
a thyroid (4). Thyroidless frogs did not morph without the presence of iodide in their 
diet (4). More recently, IYD was detected in the olfactory epithelium, cerebellum, 
pituitary glands, and epithelial cells of tadpoles (7). In zebrafish, mRNA of IYD was 
detected as early as 38 hours postfertilization in developing thyroid tissue and 




postfertilization (35). After metamorphosis, reduced expression of functional 
differentiation markers (IYD, thyroid peroxidase, and thyroglobulin) was observed 
(35) meaning expression of these proteins is only seen in larvae, not in the adults. 
1.5 Specific Aims 
Characterization of IYD has been long overdue since it was originally 
identified over 60 years ago. Only over the last six years has significant progress has 
been made understanding IYD catalysis. My research has focused on making the 
protein available through expression in bacterial culture and tracing the evolution of 
IYD from a bacterial oxidase/reductase to a dehalogenase. 
1) For years, recombinant IYD was expressed as insoluble protein in E. 
coli. Isolation of IYD in a large scale was essential to overcome the 
cost/time commitment to mammalian cell expression. The use of 
fusion proteins was investigated in hopes to aid folding in E. coli to 
continue mechanistic analysis. 
2) The engineered protein expressed in E. coli had to be compared to the 
wild-type expressed in insect or yeast cells in order to use the 
engineered protein as a model for the wild-type. The biochemical and 
biophysical properties were examined of truncated IYD. 
3) Three amino acids were suggested to be at least partially responsible 
for substrate binding. The requirement for these amino acids was 
investigated through site-directed mutagenesis to determine which of 




4) Structurally, IYD belongs to a bacterial superfamily and has its own 
unique function within this group. The origin of IYD was studied 
through phylogenetic and bioinformatics analysis. Heterologous 











Chapter 2: Engineering IYD for isolation from E. coli 
 
2.1 Introduction 
The initial isolation of IYD required detergent extraction of thyroid 
microsomes (36). Purification was accomplished in very low yield and followed by 
precipitation and multiple chromatographic procedures (24). Limited proteolysis by 
trypsin was subsequently discovered to remove the N-terminal membrane anchor of 
IYD and release a soluble and active domain from thyroid microsomes (19). 
However, neither the purity nor stability of this fragment was sufficient for 
mechanistic and structural studies.  Only after identification of the IYD gene could it 
be cloned and expressed in cell culture (19, 37).  HEK 293 cells supported 
mutagenesis studies on IYD requiring only catalytic amounts of protein and 
demonstrated that deletion of residues 2-33 generated a soluble and stable form of the 
enzyme IYD(Δtm) (18). Further truncation of IYD to its core domain homologous to 
the NADPH oxidase/flavin reductase superfamily resulted in insoluble and inactive 
protein when expressed in HEK 293 (38).  Subsequent expression of the truncated 
gene in E. coli only resulted in insoluble protein (38). 
 Heterologous expression of proteins in bacterial hosts has been made available 
through the use of recombinant DNA technology. A high level of expression of 
recombinant proteins frequently results in misfolded and insoluble protein. A variety 
of fusion proteins exist to aid solubility and purification (39). Common fusions 
glutathione-S-transferase, NusA, and thioredoxin were expressed N-terminal of IYD 




To overcome the folding problems evident with E. coli and the limited 
material available from mammalian cell culture, methylotropic yeast Pichia pastoris 
was the next host of choice for deiodinase expression.  Expression of a soluble 
derivative of the Mus musculus gene IYD(Δtm) was not detected in the cell lysate 
after denaturing PAGE, Coomassie staining and Western blotting due to the 
discrepancy in codon usage between P. pastoris and HEK 293 (40). A synthetic gene 
was constructed to overcome the use of rare codons in P. pastoris. Recombination 
and expression of optimized IYD in P. pastoris produced detectable deiodinase 
activity although the yield of enzyme was small (41). 
IYD(Δtm) was expressed very efficiently in Sf9 insect cells utilizing the 
baculovirus expression vector system of the Bac-to-Bac® kit as described previously 
(31).  This host provided ample quantities of protein for crystallographic studies (31).  
The information yielded from the structure instigated a series of investigations 
requiring site-directed mutagenesis. Although the cell line was sufficient for wild-
type protein, expressing many variations of mutations is inconvenient. Each genetic 
mutation requires repackaging of baculovirus DNA prior to infection of Sf9 cells. 
Despite the favorable results from expression in Sf9, preparation of mutants in this 
system is not ideal because of their demand for time and materials.  
The first mutations to the IYD gene made to test the proposed cysteine 
mechanism were expressed in HEK 293 (18). Two conserved cysteine residues (C217 
and C239) found in the catalytic domain were thought to be responsible for catalysis 
(19, 38). Mutation of these cysteines to alanines resulted in active enzymes indicating 




Improper oxidation or reduction of the thiol side chain of cysteines often complicates 
expression of recombinant proteins in bacteria (42, 43). Once catalysis was 
discovered to be independent of cysteines, efforts were reinitiated to express such 
mutants in E. coli.  
The struggle to use E. coli for production has continued despite some recent 
advances in eukaryotic cell lines. This chapter will describe the many fusion protein 
expression variations for Mus musculus IYD in E. coli. Insertion of the IYD gene into 
plasmids containing thioredoxin (pET32a), glutathione-S-transferase (pGEX4T-1), 
and SUMO (pET28-SUMO) fusion proteins was tested for soluble expression of the 
truncated IYD gene. Ultimately, mutation of the cysteines and fusion of thioredoxin 
to IYD has allowed for soluble expression in E. coli.  
 
2.2 Experimental Procedures 
2.2.1 Materials 
Oligodeoxynucleotide primers were obtained from Integrated DNA 
Technologies (Coralville, IA).  All enzymes were purchased from New England 
Biolabs (Ipswich, MA).  OneShot Top10 Escherichia coli were purchased from 
Invitrogen (Carlsbad, CA) and Rosetta2 (DE3) Escherichia coli were purchased from 
Novagen (San Diego, CA). The pET plasmids and antibodies for Western blotting 
were purchased from Novagen.  All other reagents were obtained at the highest grade 





2.2.2 General Methods 
DNA isolation was performed using either a Qiaprep Mini Kit (Qiagen, 
Valencia, CA) or a GeneJet Plasmid Miniprep Kit (Fermentas, Glen Burnie, MD).  
PCR reactions were performed using an Eppendorf Mastercycler.  Agarose gel 
electrophoresis (horizontal) was performed according to Ausubel (44) using 125 V 
and a standard of Mass Mix DNA Ladder (Fermentas).  Ligations and 
dephosphorylations were performed under standard conditions using T4 ligase and 
Antarctic phosphatase, respectively (New England Biolabs, Ipswich, MA).  E. coli 
transformations were performed according to Ausubel (44) with an Eppendorf 
Electroporator 2510 (1700 V, 1 mm gap cuvette), and samples were selected against 
LB plates containing the appropriate antibiotic.  DNA sequencing was performed by 
Geneway Research (Hayward, CA) and the University of Maryland Biotechnology 
Institute (College Park, MD).   
Discontinuous SDS-PAGE gels (12 % acrylamide resolving and 5 % stacking) 
and Laemmli running buffer were prepared according to standard procedures (45) and 
run according to Ausubel (44) using 200 V and a Mini Protean 3 gel system (Bio-
Rad, Hercules, CA).  All protein gels were stained with Coomassie Brilliant Blue.  
Electrophoretic transfer of proteins from SDS-PAGE gels to PVDF membranes 
(Invitrogen) for western blotting was performed with a Bio-Rad Mini Trans-Blot Cell 
according to the manufacturer’s directions.  Western Blot was performed according to 
Ausubel (44) using a His•Tag monoclonal antibody, a Goat Anti-Mouse IgG alkaline 
phosphatase conjugate and fluorescence of ECF (GE Healthcare Bio-Sciences Corp., 




Corp.). UV measurements were obtained with a Hewlett-Packard 8453 
spectrophotometer (Palo Alto, CA).   
 
2.2.3 Subcloning of IYD in E. coli expression vectors 
The mouse IYD gene (GenBank accession number: BC023358) was cloned 
into respective expression vectors and transformed into Rosetta2 E. coli. Many of 
these vectors included fusion proteins (glutathione transferase, NusA, thioredoxin, 
SUMO) to aid in folding of mouse IYD.  
A truncated (2-33) and his-tagged (His6) variant of the mouse IYD gene 
(IYD(Δtm)) and the gene with two cysteine to alanine mutations (C217A and C239A 
(IYD(∆tm)DM)) were amplified from the pcDNA3.1(+) plasmid constructed 
previously (18) using primers 5’-AAGCTTAAGCTTGGATCCGCCACCATG 
GCTCAAGTTCAGCCC-3’ and 5’-CTCGAGCTCGAGCTAATGGTGATGGTG 
ATGGTGTACTGTCACCATGATC-3’. The resulting PCR product was digested 
with BamHI and XhoI. The genes were individually ligated to various plasmids with 
T4 ligase and used to transform OneShot Top10 cells.  DNA was extracted from 
colonies resistant to the appropriate antibiotics and sequenced to confirm the presence 
of the proper insert.  Plasmids were then used to transform electrocompetent Rosetta2 
E. coli for expression. 
Cloning of IYD into pET21a 
 
The vector pET21a and PCR products IYD(Δtm) or IYD(Δtm)DM were 
digested with BamHI and XhoI.  The resulting two fragments (linear pET21a and one 




coli.  The gene insertion product was confirmed by restriction mapping with PstI and 
PflmI and DNA sequencing.  
Cloning of IYD into pET32a 
 
The vector pET32a and PCR products IYD(Δtm) or IYD(Δtm)DM were 
digested with BamHI and XhoI.  Linear vector and genes were ligated and 
transformed. Insertion of the gene in pET32a was confirmed by digestion with PstI 
and double digestion with BamHI and StuI as well as DNA sequencing.  
Cloning of IYD into pGEX4T-1 
 
Digestion of plasmids pET32a-IYD(Δtm), pET32a-IYD(Δtm)DM, and 
pGEX4T-1 by BamHI and XhoI was performed. The genes IYD(Δtm) and 
IYD(Δtm)DM were ligated to linear pGEX4T-1 and transformed in to OneShot 
Top10 E. coli.  Proper insertion of the gene was confirmed by digestion with PstI and 
double digestion with BamHI and StyI.  
Cloning of IYD into pET28-SUMO 
The pET28-SUMO vector and pET32a-IYD(∆tm)DM were digested with 
BamHI and XhoI. The IYD(Δtm) gene was ligated to linear pET28-SUMO and 
transformed into OneShot Top10 E. coli. Proper insertion was confirmed by 
sequencing with the T7 promoter primer. 
Mutagenesis of polyhistidine  tags 
After construction of the pET32a-IYD(Δtm)DM plasmid expression of the 
thioredoxin fusion protein TRX-IYD(Δtm)DM would contain two polyhistidine  




the commercial pET32 plasmid at the C-terminus of the fusion protein thioredoxin 
and the second His6 is at the C-terminus of the mouse IYD gene.  After proteolysis 
with enterokinase, both the thioredoxin fusion and IYD(Δtm)DM would contain a 
His6. Separation of the mixture of these two in solution is no longer trivial. Both of 
the 18 base pair hexahistidine sequences were mutated in order to ease purification of 
thioredoxin from IYD. Two subsequent site-directed mutagenesis reactions were run 
requiring mutation of four DNA bases causing a change in three amino acids to 
remove the His6 which was C-terminal of TRX.  The first PCR reaction of site-
directed mutagenesis used forward primer 5’-GCCGGTTCTGGCCATATGCACAA 
TATTCATCTTCATTCTTCTGGTCTG-3’ and its reverse complement containing a 
SspI site to change the second, third, and fifth His to Asn, Ile, and Leu, respectively. 
The second PCR reaction required forward primer 5’- GCCGGTTC 
TGGCCATATGTACAATATGCAGCTTAATTCTTCTGGTCTG-3’ containing a 
BsrGI site and its reverse complement creating the final amino acid sequence Tyr-
Met-Asn-Gln-Leu-Asn. Following the PCR reaction, the solution was treated with 
DpnI for four hours at 37°C to remove the template plasmid. The remaining plasmids 
were transformed into One Shot Top10 E. coli. Restriction digestion and DNA 
sequencing confirmed each round PCR mutagenesis followed by expression in 
Rosetta 2 E. coli. 
Removal of C-terminal polyhistidine tag 
The C-terminal polyhistidine tag was removed by site directed mutagenesis. 
The forward primer 5’- CTGGACCAGATCATGGTGACCGTATAGCATCACC 




BstEII restriction site and a stop codon (in bold) immediately following the gene. 
Following the PCR reaction, the solution was treated with DpnI for four hours at 37 
°C to remove the template plasmid. The remaining plasmids were transformed into 
OneShot Top10 E. coli.   Restriction digestion with BstEII and DNA sequencing 
confirmed mutagenesis prior to expression in Rosetta2 E. coli.  
 
2.2.4   Expression in E. coli 
For expression in E. coli, Rosetta2 cells containing a vector with IYD gene 
were grown in LB media with the appropriate antibiotic at 37 °C to an OD600 of 0.7.  
The cells were cooled to 18 °C (30 min), induced by addition of 0.4 mM isopropyl-β-
D-thiogalactopyranoside (IPTG) and incubated with shaking for 4 hrs (18 °C).  Cells 
were harvested by centrifugation at 3,000 x g for 5 min. The cell pellet was 
resuspended in 500 mM sodium chloride, 50 mM sodium phosphate (pH 8), 10 mM 
imidazole and lysed by three passages through a French press at approximately 
10,000 psi. Lysates were centrifuged at 20,000 x g for one hour and the supernatant 
filtered (0.22 µm).  The insoluble protein pellet was resuspended to a volume equal to 
that of the supernatant.   
Attempts to aid protein folding in vivo  
Rosetta2 cells containing pET21a-IYD(Δtm) were grown in LB at 37 °C with 
shaking. Final concentrations of 5 mM betaine, 0.5 M NaCl, or 10 mM benzyl alcohol 
were added to cells at OD600 = 0.5 (46, 47).  The flasks were allowed to shake at 18 
°C for twenty minutes before the addition of 0.1 – 1 mM IPTG for four hour 




Another method to aid solubility is to heat shock the cells prior to induction 
(48). This was tested by growing Rosetta2 cells containing pET21a-IYD(Δtm) to an 
OD600 = 0.5 then moved to a 42 °C water bath for 30 minutes.  The cells were then 
induced with 0.5 mM IPTG and incubated at 18 °C for four hours (shaking).  Cells 
were harvested by centrifugation at 5000 x g for 5 minutes.  
Refolding studies were conducted on IYD(Δtm)DM expressed from pET21a 
in Rosetta2 E. coli.  The pellet containing improperly folded IYD was resuspended in 
30 mL denaturing lysis buffer (6 M guanidine HCl, 20 mM sodium phosphate (pH 
7.8), 500 mM NaCl). This was centrifuged to remove any remaining insoluble 
proteins. The solublized protein was dialyzed overnight at 4 °C in three separate 
buffers (Buffer A: 50 mM Tris (pH 8.2), 21 mM NaCl, 0.88 mM KCl, 0.015 mM 
FMN; Buffer B: 50 mM sodium phosphate (pH 7.4), 100 mM KCl, 0.015 mM FMN; 
Buffer C: 50 mM Tris (pH 7.4), 100 mM KCl, 2 mM PEG-4000, 0.015 mM FMN) at 
two different concentrations of protein. The dialyzed protein was centrifuged for 
thirty minutes at 18,000 × g at 4 °C.  The soluble and insoluble proteins were 
analyzed by gel electrophoresis.  
2.2.5 Purification of IYD(Δtm)DM 
TRX-IYD(Δtm)DM was purified on a Hi-Trap HP column (1 mL) chelated 
with Ni2+ using an AKTA FPLC (GE Healthcare Bio-Sciences Corp.).  Soluble 
lysates were applied to the affinity column, washed with 5 column volumes of wash 
buffer (500 mM sodium chloride, 50 mM sodium phosphate pH 8.0, 20 mM 




The pooled fractions were dialyzed against 0.2 M Tris-HCl pH 7.4.  Enterokinase was 
then added to the dialyzed protein, and the resulting solution was incubated overnight 
at 18 °C.  IYD(Δtm)DM was separated from TRX by anion exchange (Mono Q, GE 
Healthcare Bio-Sciences Corp) using a wash of 5 column volumes of 0.2 M Tris-HCl 
pH 7.4 and elution with a linear gradient of 0-1 M NaCl in 0.2 M Tris-HCl (pH 7.4). 
Fractions containing the deiodinase were identified by SDS-PAGE and then pooled 
and dialyzed against 10 mM potassium phosphate pH 7.4.   
The concentration of enzyme-bound FMN was determined by A450 (ε450 
12,500 M-1 cm-1) (49) and the concentration of deiodinase was likewise determined 
by A280 using an extinction coefficient of 38,000 M-1 cm-1 calculated by ProtParam 
(50). The contribution at 280 nm from FMN was subtracted from the total absorbance 
at 280 nm to calculate the protein concentration. 
 
 
2.3 Results and Disucssion 
Efforts to induce soluble protein expression in E. coli resulted in many 
plasmids with different fusion proteins. Only two of the plasmids resulted in soluble 
protein that was then used to express and purify IYD. A list of each plasmid 
constructed is provided in Appendix A.  
 
2.3.1 IYD expressed as insoluble protein in E. coli 
Expression of non-fusion IYD(Δtm) and its double mutant from pET21a at 18 
°C yielded insoluble protein (Figure 2.1). The addition of salt, betaine, and benzyl 




IYD(∆tm) (figure not shown). However, heat shock treatment (42 °C) slightly 
increased the amount of soluble IYD(Δtm) seen in Figure 2.1. This serves as a good 
indication that heating cells to 42 °C prior to induction with IPTG could work in 
conjunction with another method that also increased the amount of soluble protein 
produce in vivo.  
 
Figure 2.1 Denaturing PAGE analysis of IYD(∆tm) (~30 kD) expression from pET21 
with and without heat shock prior to induction by IPTG. Cells were incubated at 
either 18 °C or 42 °C for 30 minutes prior to induction. Lanes are labeled for 
molecular weight standards (M), untransfected cells (Un), whole cell lysate (W), 




Refolding of IYD(∆tm)DM from pET21a was accomplished by dialyzing two 
protein concentrations (4 µM and 20 µM) into either potassium phosphate or Tris 
buffers, at various pH, with different salts, and excess FMN.  None of the six samples 
show significant amount of soluble protein (Figure 2.2). Obtaining soluble protein by 





Figure 2.2 Denaturing PAGE analysis of refolding of IYD(∆tm) (high: 20 µM and 
low 4 µM) expressed from pET21 in three buffer conditions (Buffer A: 50 mM Tris 
(pH 8.2), 21 mM NaCl, 0.88 mM KCl, 0.015 mM FMN; Buffer B: 50 mM sodium 
phosphate (pH 7.4), 100 mM KCl, 0.015 mM FMN; Buffer C: 50 mM Tris (pH 7.4), 
100 mM KCl, 2 mM PEG-4000, 0.015 mM FMN)  Lanes include marker (M), soluble 
(S) and pellet (P). 
 
 
IYD(Δtm) and IYD(∆tm)DM genes were cloned into the pGEX4T-1 vector 
and expressed in Rosetta2 cells. As seen in Figure 2.3, both constructs (IYD(∆tm) and 
IYD(∆tm)DM) were expressed as insoluble protein. This fusion protein was 
expressed concurrently as vectors with other fusion proteins were expressed. The 
remaining constructs were evaluated before further conditions were attempted to aid 





Figure 2.3 Denaturing PAGE analysis of pGEX4T-1-IYD(Δtm) expressed in Rosetta2 
E. coli. Expressed protein is indicated by the arrow at ~50 kD. Lanes include marker 
(M), soluble supernatant (S), and pellet (P) after lysis and centrifugation. 
 
 
2.3.2 IYD(Δtm)DM expressed as soluble protein in E. coli 
After various attempts of expressing IYD(∆tm) in E. coli using fusion proteins 
provided here and from previous studies (38), the only soluble constructs were using 
the pET32a vector with thioredoxin (TRX) fusion and pET28-SUMO with SUMO 
fusion (Figure 2.4).  Each plasmid expresses a fusion protein with a polyhistidine 
sequence, a proteolytic cleavage site, and IYD(Δtm)DM followed by a C-terminal 
polyhistidine sequence. Soluble protein (TRX-IYD(Δtm)DM and SUMO-
IYD(Δtm)DM) can be found after expression at 18 °C in the lanes labeled in lane S in 
Figure 2.5. Following proteolysis to remove the fusion protein, His6 is present on both 





Figure 2.4 Schematic of fusion protein and IYD(∆tm)DM.  (A) Thioredoxin fusion 
protein expressed from pET32a and (B) SUMO fusion protein expressed from pET-
28-SUMO. Abbreviations indicate TRX: thioredoxin gene, SUMO: psmt3 gene, His6: 





Figure 2.5 Denaturing PAGE analysis of fusion-IYD(∆tm)DM expressed as soluble 
protein (A) from pET32a and (B) from pET28-SUMO in Rosetta2 E. coli. Lanes 




Since His6 is present on both of the cleaved proteins, a Hi-Trap chelating 
column is not an advantage to separate the mixture of IYD and the fusion protein in 
solution. The removal of one of the two His6 sequences would ease the separation of 
IYD from the fusion protein. The fusion protein has two His6 tags and it is possible 
that one of the two or both had affinity for the column so the initial Hi-Trap 




polyhistidine tag in expression of pET32a-IYD(∆tm)DM resulted in insoluble protein. 
The insoluble IYD(∆tm)DM protein without the C-terminal His6 can be seen in 
Figure 2.6. The protein expressed without the intermediate His6 linking thioredoxin 
with IYD(Δtm)DM can be found in the pellet in Figure 2.7. Neither construct 
produced soluble protein when one of the two His6 was removed. Affinity of 
IYD(Δtm)DM to a Ni+2 column will not be the ideal way to complete its purification 
because the fusion protein will also have affinity to the column. 
 
 
Figure 2.6 Denaturing PAGE analysis of TRX-IYD(∆tm)DM expressed in pET32a 
without a C-terminal His6. Protein is indicated by an arrow at ~50 kD. Lanes include 
whole cell lysate (W), soluble (S) and insoluble (P) proteins after lysis and 








Figure 2.7 Denaturing PAGE analysis of TRX-IYD(∆tm)DM expressed in pET32a 
without the intermediate His6. Fusion protein is indicated by the arrow at ~50 kD. 
Lanes represent marker (M), whole cell lysate (W), and soluble (S) and insoluble (P) 
after lysis and centrifugation. 
 
 
Since each of the fusion proteins (TRX and SUMO) and IYD(Δtm)DM have a 
His6 sequence, a HiTrap Chelating column can no longer support purification. Other 
protein purification methods are available including anion or cation exchange based 
on overall charge (pI) and gel filtration based on size. In order to best assess which 
fusion protein to continue to use for production of IYD(Δtm)DM, we can consider the 
chemical differences between the fusion proteins in comparison to our protein of 
interest. The two fusion proteins are both dimers of about 30 kD and IYD(Δtm)DM is 
a dimer that is approximately 60 kD. Gel filtration can separate either fusion protein 
from IYD(Δtm)DM. Separating proteins of these sizes will require a long column and 
a slow flow rate. This process can be long requiring a lot of time on a machine that is 
in high demand. The major difference in the two fusion proteins is their pI (Table 2-
1). The charge difference between thioredoxin and IYD(∆tm)DM allows for 
separation on the MonoQ anion exchange column whereas the similarities in pI of 




separate IYD(Δtm)DM from the mixture with its fusion protein, the thioredoxin 
fusion system (pET32a) was selected for production of IYD(∆tm)DM.  
 
Table 2-1. pI of proteins calculated by ProtParam(51). 
Protein pI 
IYD(∆tm)DM His6 6.1 
Thioredoxin His6 5.4 
His6 SUMO 6.2 
 
 
Isolation of the desired IYD(Δtm)DM required two chromatographic steps.  
First, its fusion protein was isolated by affinity of the His6 sequence. TRX-
IYD(Δtm)DMHis6 eluted off a HiTrap Chelating HP column with imidazole over a 
range of 10 fractions with two distinct peaks which contained the fusion protein as 
evidence by a band at 50 kD on SDS-PAGE. The latter of these peaks was yellow 
indicating bound FMN while the other was clear. Since both TRX and IYD(Δtm)DM 
are dimers, it is possible that the first protein that eluted (peak that was not yellow) 
was the fraction that had TRX as a dimer. This would mean that IYD(Δtm)DM was in 
monomeric form and did not have a bound FMN. This theory is also supported by the 
fact that the intermediate His6 between TRX and IYD(Δtm)DM would perhaps have 
less affinity to the column than a C-terminal His6. The pooled fractions were 
simultaneously dialyzed and digested with enterokinase. IYD(Δtm)DM His6 was next 
separated from TRX His6 using a MonoQ anion exchange column to yield over 10 mg 




included a small fraction (27 %) of deiodinase that had been further truncated by 
enterokinase (lane MonoQ in Figure 2.8). This would arise from cleavage at the N-
terminus since the C-terminal His6 was still detected by Western blotting (Figure 
2.8B).  Collectively, the pooled fractions of deiodinase contained 1.9 FMN per native 
enzyme dimer.  
 
 
Figure 2.8 IYD(∆tm)DM purified from pET32a in Rosetta2 E. coli. (A) Denaturing 
PAGE analysis of TRX-IYD(∆tm)DM expressed in pET32a. Lanes identify the 
marker (M), whole cell lysate (W), soluble and insoluble proteins in the pellet after 
lysis and centrifugation (S and P, respectively). Ni+2 and MonoQ indicate proteins 
collected after HiTrap and MonoQ columns. (B) Western with anti-His antibodies 




Two cysteines are present in the NADH oxidase/flavin reductase domain of 
all mammalian iodotyrosine deiodinases characterized to date.  The native oxidation 




possible cause for misfolding and inclusion body formation when various constructs 
of this enzyme were first expressed in E. coli (38). Contrary to our original 
expectation, a C217A; C239A double mutant (DM) of the deiodinase retained 
significant catalytic activity (18). Since these two cysteines that perhaps were causing 
misfolding are not necessary, this gene could then perhaps provide soluble protein 
when expressed in E. coli. Thus, expression of the enzyme was again attempted in E. 
coli using various fusion proteins with IYD(Δtm)DM.  Ultimately, soluble protein 
was expressed from a gene encoding an N-terminal thioredoxin fusion and 
polyhistidine tags at the C-terminus and in the linker region between the TRX and 
IYD(Δtm)DM gene (Figure 2.7A). Use of other fusion proteins in place of TRX, 
removal of either His6 sequence, or lack of cysteine to alanine mutation resulted in 




Chapter 3: Characterization of IYD  
 
3.1 Introduction 
Initial reports of iodotyrosine deiodinase describe extraction and purification 
of the enzyme from bovine thyroids (36). From the small amounts of homogeneous 
protein (0.75 mg) recovered from thyroid tissue (1 kg), the authors began biochemical 
characterization (23, 24). This allowed for initial examination including molecular 
weight, flavin content, pH dependence of catalysis, specific activity, and reduction 
potentials of oxidized and reduced enzyme. Complete characterization of IYD 
requires large amounts of pure protein. Once the DNA sequence of IYD was 
discovered, the gene was manipulated for expression in HEK 293, Pichia pastoris, 
Sf9, and E. coli (40). DNA technologies allow for DNA manipulation to create 
recombinant proteins. 
Presented here is the first time that the IYD gene was engineered for 
expression in E. coli after years of different attempts (38, 40). Heterologous 
expression in Sf9 and P. pastoris supported expression of significant amounts (mg) of 
soluble IYD (40). Although these cell lines offered enough protein for initial 
characterization, they are inconvenient for studies using site directed mutagenesis. 
These expression systems are time consuming and not amenable to mutagenesis to 
further study the protein. Soluble expression in E. coli was the key step to create 
mutants. In order to do this, however, we first must validate that the mutant protein 




counterpart expressed in human, yeast, and insect cell lines. Specific activity, 
substrate binding, and the structures are all compared herein. 
 The wild-type enzyme without its membrane domain (IYD(Δtm)) expressed in 
Sf9 cells was crystallized. The first holo-enzyme structure was solved by sulfur 
phasing and additional co-crystal structures were solved by molecular replacement 
(31). The structure confirmed the placement of IYD in the NADPH oxidase/flavin 
reductase structural superfamily. The enzyme forms a homodimer with two individual 
active sites which each bind a molecule FMN and substrate.  
Pure enzyme allows for calculations of accurate enzyme kinetics and substrate 
binding calculations. Michaelis-Menten kinetic constants were obtained for 
IYD(Δtm) through the use of a discontinuous assay measuring the release of 
radioactive iodide from DIT. Equilibrium binding of substrate to IYD(Δtm) to 
calculate a binding constant was performed via the inherent fluorescence of FMN 
bound to the protein. The values for IYD(Δtm) are the basis for understanding the 
enzyme and are used as a comparison for the validity of specific mutations. 
It is especially important that we observe wild-type-like enzymatic features 
for this double cysteine mutant IYD(Δtm), noted as IYD(Δtm)DM. Expression in E. 
coli is only a useful tool if the protein can be used as a model of wild-type enzyme to 
make mutations to study mechanistic properties. Therefore, IYD(Δtm)DM must 
display similar enzymatic parameters and similar structure to IYD(Δtm) in order to 
make additional mutations to IYD(Δtm)DM to investigate the biochemical properties 








Protein was expressed and purified as previously described (Chapter 2). UV 
measurements were obtained with a Hewlett-Packard 8453 spectrophotometer (Palo 
Alto, CA). Circular dichroism spectra were collected with a Jasco J-810 
spectropolarimeter (Easton, MD).  A Hitachi F-4500 fluorescence spectrophotometer 
was used to collect fluorescence spectra (Schaumburg, IL). 125I used for radiolabeling 
was purchased from Perkin Elmer (Waltham, MA). Radiation was counted on a 
Packard 1600 TR liquid scintillation counter.  
 
3.2.2 Circular Dichroism 
CD spectra were taken of IYD(Δtm) and IYD(Δtm)DM. Ten measurements 
were made of 300 µl protein in 10 mM potassium phosphate (pH 7.4) with and 
without 300 µM MIT in a 0.1 cm cuvette.  Spectra were collected at two protein 
concentrations (4 µM and 60 µM) for the far-UV (190 nm – 300 nm) and visible 
wavelengths (300 nm – 500 nm), respectively. Spectra were averaged and buffer 
contributions were subtracted from data. 
 
3.2.3 Fluorescence quenching 
Substrate dissociation constants were calculated based on the change in 
fluorescence of flavin bound to protein upon titration of substrate. Fluorescence 
measurements were recorded at λem 525 nm (λex 450 nm) two minutes after each 




fluorescence from the initial fluorescence intensity and plotted against substrate 
concentration. Dissociation constants (KD) were calculated according to
 
Equation 





3.2.4 Deiodinase activity 
Deiodination of 125I radiolabeled diiodotyrosine by IYD(Δtm)DM was 
measured by a discontinuous assay (19, 53). Briefly, solutions (radiolabeled 
diiodotyrosine (20,000 cpm), 100 mM potassium phosphate (pH 7.4), 200 mM KCl, 
50 mM β-mercaptoethanol, 0.50 mM methimidazole, and 30 µM FMN) containing 
enzyme. Reactions were initiated by dithionite and incubated for 30 minutes at 
ambient temperature with unlabeled DIT (0 – 300 µM). The reactions were loaded on 
a cation exchange column and eluted with two column volumes of 10 % (v/v) acetic 
acid. A sample of the reaction solution prior to separation (dpm1), as well as the two 
collected fractions collected after ion exchange (dpm2 and dpm3, each one column 
volume) were counted. The rate (V) was calculated by subtracting the ratio of eluted 
125I (F) from the background radiation (F0) as seen in equations 3-2 and 3-3, where t 
is the time (hours) after initiation and n is the moles of DIT (nmol). The value is 
multiplied by a coefficient of 2 because two deiodination sites exist on the DIT 




Kinetic constants were calculated by fitting the data of three independent assays to 
the Michaelis-Menten equation in Origin 7.0.  
 




       Equation 3-3 
 
 
3.2.5 Crystallization of IYD(Δtm)DM  
IYD(Δtm)DM crystallized using the hanging drop diffusion method at one 
part enzyme (10 mg/ml; 10 mM potassium phosphate, pH 7.4) to one part reservoir 
solution containing 0.2 M ammonium acetate, 0.1 M BisTris (pH 6.5), and 45% v/v 
2-methyl-2,4-pentanediol. IYD(Δtm)DMMIT co-crystals formed at 20 °C in 15% 
w/v PEG 10,000, 20% glycerol, 0.1 M citric acid (pH 5.5). Crystal diffraction data 
was collected using a Brucker Microstar H2 generator with a Proteum Pt135 CCD 
detector at 100 K at a wavelength of 1.54178 Å and 0.9795 Å for the protein complex 
with MIT. Data were integrated and scaled using Proteum. Molecular replacement 
was performed by PHASER in the CCP4 program suite. The structures were refined 







Table 3-1. Crystallographic parameters of IYD(∆tm)DM and its co-crystal with MIT. 
 IYD(Δtm)DM IYD(Δtm)DM • MIT 
PDB Code: 3TO0 3TNZ 
Data Collection   
Space group P31 P3 
Cell dimesions   
a, b, c (Å) 87.270, 87.270, 62.725 108.98, 108.98, 49.39 
α, β, γ (°) 90.00, 90.00, 90.00 90.00, 90.00, 120.00 
   
Molecules/ Asymmetric Unit 2 2 
   
Wavelength (Å) 1.54187 0.9795 
Resolution (Å) 19.88-2.66 50-2.25 
Rsym (last shell) 0.105 0.15 
I/σI 73 12.4 
completeness (%) 99.71 99.7 
Redundancy 3.7 8 
   
Refinement   
Resolution (Å) 28.566-2.655 26.5-2.248 
Rwork/Rfree(%) 18.23/23.69 17.2/20.0 
Number of protein residues 
per monomer 221/222 221/221 
   
Number non-protein atoms   
Ligand 80 128 
Solvent 50 298 
Mean B-factors (Å)2 6.14 10.05 
RMS deviations   
Bond lengths (Å) 0.015 0.014 
Bong angles (°) 1.639 1.384 
Ramachandran plot   
Most favorable 94.96% 97.00% 
Additionally allowed 4.76% 2.50% 





3.3 Results and Discussion 
Earlier studies characterized IYD that was extracted from microsomes, 
solublized by trypsin digest, and extensively purified. KM values, calculated by 
double reciprocal plots, were determined to be 2.5 µM for DIT (24). Enzyme turnover 
was approximately 10 min-1 for DIT (24). It was in this study that the addition of 
thiols (50 mM β-mercaptoethanol) and high ionic strength (200 mM KCl) were noted 
to increase the observed enzyme activity (24). Subsequent studies noted the reduction 
of the enzyme by stoichiometric amounts of dithionite and enzyme could not be 
activated by photoreduction with EDTA (23). Oxidation-reduction potentials were 
calculated at -412 mV for the oxidized and -190 mV for the reduced enzyme (23). 
These values are impressively similar to our findings despite the authors’ now archaic 
protein purification methods. This can serve as a good model that comparable results 
are obtained from homogenated protein solubilized by trypsin digest and 
heterologously expressed protein. 
 Here, we have biochemically characterized heterologously expressed and 
purified IYD. The protein was expressed with an N-terminal thioredoxin fusion 
protein in E. coli. Proteolytic digestion and further purification yielded 11 mg/L at an 
acceptable 80% purity with a 1:1 FMN:IYD ratio (Chapter 2). This protein was used 
for the experiments described below.  
 
3.3.1 CD of flavoprotein iodotyrosine deiodinase 
Circular dichrosim is a technique used to study the secondary structure of 




monitored by changes in the spectra. CD spectra in the far-UV region of IYD(Δtm) 
and IYD(Δtm)DM are shown in Figure 3.1 and Figure 3.2. The α-helical and β-sheet 
content of each protein as predicted by K2D2 (54) (57 % and 8 %, ) is within error of 
the calculated content from the crystal structure (3GB5; 42 % and 9 %). Mutation of 
the cysteine residues did not alter the amount of α-helical or β-sheet (compare panel 
A and B in Figure 3.1), as predicted by K2D2. This was expected based on detectable 
activity from the previous expression of these mutants in HEK 293 cells (18).  
 
 
Figure 3.1 Far-UV CD of IYD(∆tm). Protein (4.5 µM) with (red) and without (black) 




CD spectra collected in the visible region presents useful information about 
the flavin environment. Each flavoprotein has distinct signature CD spectra in the 
visible range (300-500 nm) based on the amino acids and secondary structure 
surrounding the flavin and oxidation state of the flavin (55).  Protein for the visible 
spectra was 15-fold more concentrated than the far-UV data in order to detect 
significant change in ellipticity. IYD(Δtm) has positive peaks at 340 and 450 nm. The 




conclude that the flavin environment is the same in IYD(Δtm) and IYD(Δtm)DM; 
same orientation, oxidation state, exposure to solvent (Figure 3.2, black lines in panel 
A and B).  Every flavoprotein has a distinct CD spectra depending on the amino acids 
surrounding the flavin (56). Seeing these two proteins have the exact same CD 
spectra indicate that they have the same amino acids surrounding and stabilizing the 
bound flavin.  
More interestingly, upon the addition of saturating substrate, a significant 
change in ellipticity is observed. A new negative peak is observed at 350 nm in the 
presence of substrate. This is thus a change in the flavin environment, perhaps due to 
the stacking of the MIT aromatic ring over the isoallaxozine ring of FMN.  
The similarity in visible region CD spectra when comparing IYD(Δtm) and 
IYD(Δtm)DM designate that the flavin is equivocally bound to the wild-type and 
mutant proteins. Upon substrate binding to either wild-type or mutant protein, we 
observe the same shift in the ellipticity in the visible CD spectra. The difference in the 
CD spectra between samples with and without substrate present indicate that the 
chemical environment surrounding bound FMN changes upon the addition of 
substrate. We see the same shift in wild-type and mutant proteins with substrate 
present indicating that both proteins provide for the same interaction between FMN 





Figure 3.2 CD of visible region of IYD. Protein (60 µM) with (red) and without 




3.3.2 Kinetics of IYD(Δtm)DM  
Kinetic parameters of heterologously expressed and purified IYD have been 
previously published. Removal of the transmembrane domain resulted in no change in 
the kcat/KM values for reactions initiated with dithionite when expressed in HEK 293 
cells (18). However, this truncation did remove the ability of NADPH to reduce FMN 
in vitro (18). Expression of the truncated enzyme in Sf9 and P. pastoris provided 
similar kinetic values to each other as well as to the comparable sequence expressed 
in HEK 293. Previously, the double cysteine mutant was expressed as the full length 
gene in HEK 293 cells and displayed two fold lower kcat/KM  (18).  
Deiodination of IYD(Δtm)DM was found to have similar kinetic parameters 
as the enzymes expressed in HEK293 cells. A comparison can be made of IYD(Δtm) 
and IYD DM expressed in HEK 293 and Sf9 to IYD(∆tm)DM expressed in E. coli as 
seen in Table 3-2. Regardless of the version of the protein, IYD has very similar 




coli have virtually the same KM and kcat. This is further indication that IYD(Δtm)DM 
will be a useful model to use for further mechanistic studies. 
 
Table 3-2. Catalytic properties of iodotyrosine deiodinase (Mus musculus) 
derivatives. 
  DITa MIT 
  kcat  KM   kcat/KM KD 
Source Enzyme (min-1) (µM) (min-1 µM-1) (µM) 
HEK293 IYDb 7.1 ± 0.9 8 ± 3 0.89 ± 0.35 - 
HEK293 IYD (Δtm)b 5.8 ± 0.6 6 ± 2 0.95 ± 0.33 - 
HEK293 IYD DMb 16 ± 2 42 ± 7 0.38 ± 0.08 - 
 Pichia IYD (Δtm) 6.9 ± 1.3 19 ± 3 0.36 ± 0.09  
Sf9 IYD (Δtm) 4.5 ± 0.7 9 ± 1 0.49 ± 0.09 0.09 ± 0.04c 
E. coli IYD (Δtm)DM 9.3 ± 1.6 40 ± 5 0.23 ± 0.05   2 ± 0.2  
aKinetic measurements based on deiodination were fit to Michaelis-Menten kinetics. 
bData  from HEK 293 expression were determined previously (18). cFrom McTamney 
and Rokita (26).  
 
 
3.3.3 Equilibrium binding to IYD(Δtm)DM 
Dissociation constants of MIT to IYD(Δtm)DM were calculated by Origin 7.0 
using titration curve data (Table -2).   The two cysteine mutations reduce the affinity 
of the enzyme for substrate compared to the wild-type enzyme, IYD(Δtm) (Table -2). 
The assay for the mutated protein was performed at 3x higher concentration than that 
of wild-type. When the assay was performed at a lower protein concentration (1.5 
µM), only 30% decrease in fluorescence was observed. Upon increasing the protein 
concentration (4.5 µM), eighty percent of the fluorescence was quenched with 
saturating amounts of substrate. This phenomenon could be due to the structural 
stability of the mutated enzyme. It is possible that the protein would not be a stable 




type. This is not confirmed by experimental data but could be reviewed by 
sedimentation equilibrium experiments. The protein concentration does not affect the 
calculation of the substrate binding constant. Regardless of the protein concentration 
necessary to observe the change in fluorescence, there is a twenty-fold decrease in 
MIT affinity when comparing IYD(Δtm)DM to IYD(Δtm). This is a change worth 
noting, but not significant enough to retract the claim that the protein is a good model.  
 
Figure 3.3 Binding titration of MIT to IYD(∆tm)DM . Ligand binding was monitored 
by the change in fluorescence of the flavin bound to IYD using λex of 450 nm and λem 
of 527 nm. Solutions of IYD (4.5 µM) in 10 mM potassium phosphate (pH 7.4) at 25 
°C were titrated with MIT (0-250 µM). Three independent titrations were recorded 
and the fluorescence intensities were corrected for the slight dilution caused by the 
addition of ligand, normalized, and plotted against MIT concentration. 
 
 
3.3.4 Crystal structure of IYD(∆tm)DM 
The crystal structures of IYD(Δtm)DM and its complex with MIT were 




perturb the enzyme structure.  C217 is located at the interface of the homodimer, and 
C239 is closer to the protein surface but still protected from solvent (Figure 3.4). 
Removal of the two cysteines did not affect protein crystallization. In fact, IYD(Δtm) 
and IYD(Δtm)DM both crystallized with 0.2 M ammonium acetate, 0.1 M BisTris 
(pH 6.5 and 5.5, respectively) and 45 % v/v 2-methyl-2,4-pentanediol.  The structures 
of IYD(Δtm)DM and IYD(Δtm)DM•MIT were solved by molecular replacement and 
remained very consistent with the parent structures In the absence of MIT (Figure 
3.4), the active site appeared very accessible to solvent due to a lack of detectable 
structure in two surrounding regions of the polypeptide.  
 
Figure 3.4. IYD(∆tm)DM crystal structure. IYD(∆tm)DM (PDB ID: 3TO0) 
crystallized in the absence of substrate. Monomers are distinguished by color. 
Disordered regions (156-177 and 195-208) are not shown due to lack of electron 
density. Cysteines from 3GFD (in gray) are shown as yellow spheres. 
 
In the presence of MIT (Figure 3.5), an active site lid comprised of a helix and 




crystal with MIT had electron density for these amino acids unlike the crystal of the 
holo-enzyme. This indicates that either the active site lid is folded and flexible or that 
it is unfolded and unstructured. Either way, electron density was not detected until 
substrate was present. This lid effectively sequesters the substrate-flavin complex 
from solvent.    
The prospective use of E. coli expressed IYD(Δtm)DM•MIT as a model of 
native enzyme was validated by the very low RMSD of 0.262 Å when overlaid with 
the original IYD(Δtm)•MIT (3GFD) structure (Figure 3.4).  The small deviations in 
folding are not localized but rather distributed throughout the three dimensional 
structure. If one region was perturbed more than the rest of the structure, 
IYD(Δtm)DM would not be a good model. Deviation of less than one angstrom 
across the whole structure is insignificant which is an important trait of IYD(Δtm)DM 





Figure 3.5 Crystal structure of IYD(∆tm)DM bound to MIT. IYD(∆tm)DM (PDB ID: 
3TNZ) Structure associated with substrate binding is in purple and green with respect 
to the monomeric unit. MIT and FMN are in yellow.  
 
 
Most importantly, the active site characteristics of IYD(Δtm) and its 
C217A;C239A mutant are essentially identical.  Their co-crystals both revealed the 
same overall contacts between the protein, FMN and MIT (31). The aromatic portion 
of MIT stacks over the isoalloxazine ring of FMN, and its phenolic –OH forms 
hydrogen bonds to the 2’-hydroxyl group of the FMN ribose and the Ala126 
backbone nitrogen.  The carbon of MIT bonded to the iodide is only slightly more 
distant from the C4a of FMN than that detected in the parent enzyme expressed in Sf9 
(3.73 Å vs. 3.65 Å, respectively) (31).  The zwitterionic arm of MIT is bound through 




flavin ring and the side chains of three amino acid residues (Glu153, Tyr157, Arg178) 
as part of the active site lid (Figure 3.6).  
 
Figure 3.6 IYD(∆tm)DM active site overlayed on IYD(Δtm). MIT interactions with 
IYD and FMN are shown through polar contacts within 4Å indicated by dashed lines. 
Each monomer of 3TNZ is colored in green or purple and 3GFD is gray.  
 
 
3.4 Conclusion  
As the similarity in the crystal structure displays, the cysteine-free protein 
expressed in a soluble form in E. coli is an alternative to tedious expression systems 
necessary to express wild-type enzyme. Despite the slight deviation in kinetics and 
affinity for substrate, the double mutant (IYD(∆tm)DM) expressed from E. coli is an 
acceptable form of the protein. The protein expressed in E. coli can act as an 
alternative to the Sf9 and yeast expression systems to easily create mutations to study 
the mechanism of action. It is concluded that the cysteine mutations would allow for 





Chapter 4: Substrate coordination to the active site lid 
4.1 Introduction 
Engineering IYD for expression in E. coli not only simplifies its preparation 
but also expedites its mutagenesis. These advances were applied first to measure the 
individual contributions of three residues that were expected to be critical for 
substrate coordination. IYDs unique function within its structural superfamily makes 
the study of its activity and substrate recognition much more interesting.  
Active site lid structures in flavoproteins are common and do not share overall 
structural similarities or function.  Flavoproteins with active site lids act as oxidases 
(57), dehydrogenase (32), bioluminescence (58), and oxidoreductases (59). 
Specifically in the NADPH oxidase/flavin reductase superfamily, the proteins have an 
active site lid (33, 60). The flavin reductase P (FRP) from V. harveyi has a nine 
residue sequence (201-209) that did not have electron density upon solving the crystal 
structure (58). This region, and specifically two residues R203 and K208, bind 
NADPH, although no crystal structures of this enzyme have been solved with 
NADPH as the ligand (33). Other proteins in the superfamily of NOX proteins have 
crystal structures that show electron density in the structure surrounding the active 
site while others do not.  
The dynamic processes of IYD catalysis involve the binding of substrate to 
the enzyme to form the enzyme-substrate complex, the catalytic deiodination 
(turnover), and the release of products. The active site lid is involved with each of 
these steps.  Proper orientation of the substrate in the active site pocket is coordinated 




protein residues on the active site lid (31) (Chapter 3). The proximity of the two 
ligands (MIT and FMN) is critical to forming the catalytically active complex prior to 
deiodination. A network of hydrogen bonds between side chains on the lid and 
residues on the stable dimer aids in both formation of the active complex and 
sequestering the MIT-FMN interaction from solvent. Following catalysis, the 
products must be released. The active site lid has to be flexible to open away, perhaps 
like a hinge, to liberate free iodide and tyrosine.  
 
IYD’s active site lid is not positioned over the active site without substrate 
present as indicated by the lack of electron density in IYD(Δtm), PDB ID 3TO0. The 
active site lid forms a helix-turn-helix (residues 152-178) to sequester the substrate 
binding pocket from solvent. Not only does the lid have helical structure but the 
amino acids R100, N156, M161, R165, W165, D168, L169, K171, L237 from one 
chain and V205, H206, Y207, and Y208 from the other chain form a network of 
hydrogen bonds to deprive the closed active site of any external (solution) exchanges. 
None of these amino acids, except R100 and L237, have detectable structure in the 
holoenzyme crystal structure as indicated by the lack of electron density in 3TO0. 
Each is a part of what is creates the active site lid. The lack of electron density and 
formation of a sequestered active site is most prevalently seen in the difference 
between the right and left surface representations of the crystal structure in Figure 
4.1. Specifically, functional groups of only two residues (Y207 to D168) form an H-
bond over the active site. These two residues are found on opposite monomers, 





Figure 4.1 The surface properties of IYD(Δtm)DM (left) and its complex with MIT 
(right) as calculated using vacuum electrostatics in PyMOL (61).  
 
The tight pocket precludes any other substrates from fitting into the active 
site. The addition of the lid to condense over the substrate would direct the placement 
of the substrate to the FMN and block anything larger than diiodotyrosine in the 
active site. Members of the NADPH oxidase/flavin reductase structural superfamily 
bind NADPH (59) but it would not fit in the known space of IYDs active site. IYD 
needs NADPH to reduce FMN in vivo, as indicated by the lack of reduction in whole 
cell lysates in CHO cells compared to reduction in HEK 293 cells (18). Prior to the 
crystal structure, NADPH binding was not predicted for IYD (25) and a lack of 
fluorescence quenching by NADPH confirmed this (41). Similarly, a peptide 
sequence containing an iodinated tyrosine residue was unable to be deiodinated 
(unpublished work from Rokita lab). Other iodinated tyrosine substrates T3 and T4 
also would not fit in IYDs active site (31) and are likewise not processed by IYD 
(62).  The distinctive function of IYD and its substrate specificity encourage the study 




The clamping of the active site lid prevents larger substrates from entering the 
pocket. On the lid, only three amino acids hydrogen bond to the substrate. These 
residues are E153, Y157, and K178 (Figure 4.2). These three are responsible for 
orienting the substrate over the flavin to facilitate deiodination. We can discern the 
role of each of the three amino acids by mutating each to disrupt hydrogen bonding.  
 
Figure 4.2 The active site of IYD(Δtm)DM. Amino acids that make hydrogen 
bonding contacts to the MIT substrate are shown in sticks and labeled. The amino 
acid substrate MIT and cofactor FMN are in yellow. PDB ID: 3TNZ. 
 
Conservative mutations were made to the three residues that make hydrogen-
bonding contacts to the zwitterionic portion of the substrate. Glutamate interacts with 
the amino terminus of the amino acid substrate. To disrupt this interaction, the 
carboxyl group of glutamate should be sacrificed. Glutamate at 153 was mutated to 
glutamine, which retains the side chain length and replaces the functional carboxyl 
group with an amine. The second amino acid, tyrosine at 157, contacts the carboxyl 
end of the substrate. Tyrosine was mutated to phenylalanine, which removes the 




glutamine to disrupt hydrogen bonding interactions between the amino group of 
lysine and the carboxyl group of the substrate. Conservative mutations were made to 
retain the number of carbons but would disrupt the hydrogen bonding ability of the 
side chain to the zwitterionic substrate. The protein characterized in Chapter 3, 
IYD(Δtm)DM, serves as the parent enzyme for mutagenesis as it is expressed easily 
in E. coli, which is an ideal system for introducing mutations. It is predicted that each 
of these mutations will negatively affect substrate binding and catalysis.  
 
4.2 Materials and Methods 
4.2.1 General Methods 
General methods follow the same protocols described in Chapter 3. Proteins 
were expressed in Rosetta 2 E. coli and purified via two chromatographic steps in the 
same manner as described in Chapter 2. IYD(Δtm) was expressed in Pichia and 
purified as previously described (40, 41). UV measurements were obtained with a 
Hewlett-Packard 8453 spectrophotometer (Palo Alto, CA).  CD measurements were 
made on a Jasco J-810 spectropolarimeter (Easton, MD). Ten spectra were collected 
at 20 °C in a 0.1 cm pathlength quartz cuvette and averaged.  Ligand binding to IYD 
was monitored by the change in bound flavin fluorescence using λex of 450 nm and 
λem of 527 nm as reported previously (26). Catalytic deiodination of [125I]-
diiodotyrosine (DIT) was determined by discontinuous measurement of [125I]-iodide 
release described previously using DIT concentrations ranging from 1.0 to 50 µM and 




averaged, and data were fit to Michaelis-Menten kinetics using Origin 7.0 
(Northampton, MA).   
 
4.2.2 Site-directed Mutagenesis 
Mutations to the gene were generated by site-directed mutagenesis of the 
pET32A plasmid encoding TRX-IYD(Δtm)DM.  E153Q was introduced by the 
forward primer 5’-GAAGAGGAGCAAGAAATTAATTACATGAAAAGGATG 
GGAAAGCGATGGG-3’ and its reverse complement. Y157F was created by the 
forward primer 5’-GAGGAGGAAGAAATAAATTTCATGAAAAGGATGGGAA 
AGCGATGGG-3’ and its reverse complement. K178Q was formed by using the 
forward primer 5’-AGAACCAACTGGATTCAGGAGTACTTGGACACCGCC 
CCAGTTCTGATCCT -3’ and its reverse complement.  The mutated codon is 
underlined and the amino acid difference is in bold.  The desired mutation was 
confirmed by sequencing and plasmids were used to transform electrocompetent 
Rosetta 2(DE3) E. coli for expression.  
4.3 Results and Discussion 
Numerous active site residues are likely responsible for catalysis (indirectly) 
and binding of substrate and FMN. Previous studies identified key amino acids 
involved in FMN binding by sequencing the IYD gene from humans that had thyroid 
disease (14).  Later crystallographic studies identified E153, Y157 and K178 as key 
to substrate recognition (31). 
The most conservative substitutions E153Q, Y157F and K178Q were 




mutants alter the charged atoms from the amino acid that creates the hydrogen bond 
between the protein and the zwitterionic tail of the substrate. The K178Q mutant of 
IYD(Δtm)DM expressed in E. coli but was insoluble and inactive.  This was not 
pursued further.  However, the two remaining mutants alternatively containing 
E153Q and Y157F were expressed in a soluble form.  The ability of these mutants to 
bind and deiodinate substrate was examined through circular dichroism, equilibrium 
binding, and release of radioactive iodide from DIT. 
 
4.3.1 Confirmation of soluble and folded protein 
When mutations that are intended to disrupt ligand binding are made to 
proteins, it is imperative that the expressed soluble protein is folded the same with 
respect to the parent protein. Here, mutations were made to the active site lid of 
parent IYD(Δtm)DM, presented earlier. Of the three mutations created, only two 
(E153Q and Y157F) successfully folded in E. coli. The third mutation, K178Q, was 
expressed as insoluble protein in E. coli, despite similar efforts to aid solubility 
described in Chapter 2. The two purified enzymes were confirmed to have a 1:1 FMN 
to protein molar ratio. This is important because the mutant proteins must bind flavin 
in a constructive manner to perform catalysis. Proper protein folding and expected 
flavin environment are validated by circular dichroism (CD). 
 Even though many of the proteins were soluble, their ability to fold in an 
active conformation must be confirmed. CD spectra of each mutant were collected 
and overlaid for comparison of α-helical and β-sheet content (Figure 4.3). They each 




structure. Likewise, the CD spectra in the visible region (300 – 500 nm) show 
positive peaks at 340 nm and 450 nm, as well as a negative peak at 365 nm. Both of 
the mutants’ CD spectra display corresponding peaks indicating that the flavin 
environment is identical in each of the proteins. Any loss in catalytic activity cannot 
be attributed to misfolded protein or a difference in flavin environment.  
 
 
Figure 4.3 CD spectra of mutations of IYD(Δtm). Black lines indicate IYD(Δtm), 
green lines indicate Y157F, and red lines indicate E153Q. Proteins are in10 mM 
potassium phosphate (pH 7.4) at 25 °C in a 0.1 cm cuvette. a) Far-UV spectra taken 
of 4.5 µM protein. b) Visible spectra of 60 µM protein.  
 
4.3.2 Deiodinase activity of mutants 
Mutation to these two sites reduced the enzymes’ ability to deiodinate DIT. 
The loss of the phenolic group (Y157F) increased the kcat and KM values for 
deiodination by more than 7-fold and decreased the kcat/KM value more modestly by 
less than 40% (Table , Figure 4.4).  In contrast, loss of the carboxylic acid provided 
by E153 reduced the deiodinase activity to an undetectable level.  Loss of FMN from 
the active site was not responsible for these changes since its occupancy remained 
constant at one per active site in these two mutants enzymes, identical to the parent 
IYD(Δtm)DM.   Additionally, CD spectra of the deiodinase mutants indicated that 




constant (Figure 4.3a). This means that the inability for the mutated protein to 
catalyze deiodination is directly related to the amino acid substitution.  
 
Figure 4.4 Specific activity of IYD(Δtm)DM and its mutants. Three data sets were 
measured and their averages and standard deviations are shown. Kinetic constants 




Table 4-1. Catalytic properties of iodotyrosine deiodinase (Mus musculus) 
derivativesa.  
  DITa MIT 
  kcat  KM   kcat/KM KD 
Source Enzyme (min-1) (µM) (min-1 µM-1) (µM) 
Sf9 IYD (Δtm) 4.5 ± 0.7 9 ± 1 0.49 ± 0.09c 0.09 ± 0.04b 
E. coli IYD (Δtm)DM 9.3 ± 1.6 40 ± 5   0.23 ± 0.05c   2 ± 0.2  
E. coli Y157F  65 ± 16 440 ± 170 0.15 ± 0.07c 40 ± 10 
E. coli E153Q  - -   -  >1000 
 
aKinetic measurements based on deiodination were fit to Michaelis-Menten kinetics. 
bFrom McTamney and Rokita (26). cPropagation of error was calculated from the 
equation in Appendix B. 
 
Active site binding of MIT was measured independently from enzyme 




were limited by the solubility of MIT in 10 mM potassium phosphate (pH 7.4). The 
E153Q mutant expressed no measurable binding affinity for MIT, which could 
explain its lack of catalytic activity (Table -1, Figure 4.4).  Even the Y157F mutant 
weakened the binding of MIT by 20-fold relative to its IYD(Δtm)DM parent (Figure 
4.5).  Almost the same extent of binding affinity was also lost by the substitution of 
the two cysteines for alanines despite their distance from the active site (Table -1).  
The twenty-fold decrease in this case indicates that Y157 contacts are important but 
their absence does not disrupt the ability for substrate to bind. 
Kinetic and equilibrium binding studies to date indicate that E153 is required 
but not solely responsible for substrate binding.  In contrast, Y157 contributes to 
substrate binding and catalysis but is not essential.  The loss of a hydrogen bond 
provided by Y157 weakens MIT binding yet increases kcat.  Perhaps, the loss of 
binding affinity is the result of faster release of substrate and similarly faster release 
of the product tyrosine during turnover. The lid lacks a hydrogen bond that helps 
stabilize the productive formation for catalysis. Without this hydrogen bond, the lid is 
perhaps less established and would take less energy to release after catalysis.   
The lack of hydrogen bonding between the zwitterionic arm and the mutated 
residues from the active site lid might prevent proper orientation of the aromatic 
substrate to stack directly with FMN. In this case the active site lid is directing the 
substrate into the catalytic conformation. The substrate fits comfortably perfectly into 
this cavity with the lid creating an environment unexposed to solvent. The degree by 
which the active site lid can do this is governed by the few contacts made by E153 




substrate affinity and activity that the hydrogen bonding of the charged arm to the N-
3 and O4 of FMN alone are insufficient for proper orientation of the substrate as 
neither are directly involved with catalysis.  
These initial substitutions did not affect the CD spectrum in the visible region 
based on the flavin absorbance (Figure 4.6).  Both IYD(Δtm) expressed in Pichia and 
IYD(Δtm)DM expressed in E. coli generated equivalent spectra in the absence of 
MIT and responded similarly after addition of MIT.  Subsequent mutation of Y157F 
had minimal effect on CD spectra, but not surprisingly, mutation of E153Q 
dramatically diminished response to MIT (Figure 4.5).  
 
Figure 4.5 Equilibrium binding curves of IYD(Δtm)DM and its mutants.  Ligand 
binding was monitored by the change in fluorescence of the flavin bound to IYD 
using λex of 450 nm and λem of 527 nm. Solutions of IYD (4.5 µM) in 10 mM 
potassium phosphate (pH 7.4) were titrated with MIT to the extent possible. Three 
independent titrations were recorded, the fluorescence intensities were corrected for 
the slight dilution caused by the addition of ligand, normalized by dividing the 
fluorescence by the initial fluorescence and plotted against ligand concentration. 
Dissociation constants were calculated as prescribed in the literature from a nonlinear 





The substrate stacks over the flavin, creating a change in the active site 
environment. The CD spectra in visible wavelengths will change based on a shift in 
the interactions with the flavin (56). The shift could be caused by a conformational 
change in the protein structure or due to ligand binding. Differences in the visible UV 
CD are indicative of differences in the mode of binding of ligand to protein or a 
conformational shift essential for biological function (63). A change in the CD 
spectra of IYD(Δtm) after saturation with MIT is observed as a shift to a negative 
peak at 350 nm in the visible wavelengths (flavin absorption). The shift was observed 
for Y157F but not for E153Q. In the active site of Y157F, MIT must form a similar 
interaction with FMN as the parent IYD(Δtm)DM based on the sensitivity of CD in 
these wavelengths. As for E153Q, the persistent positive peak at 340 nm and negative 
peak at 370 nm in the presence of substrate indicates that no interaction occurs 
between the FMN and MIT. After the lack of activity and fluorescence quenching, it 
is no surprise that the visible CD spectra of E153Q with MIT does not change (Figure 
3.6). This is consistent with the idea that CD can detect the connection between 






Figure 4.6 Visible UV CD spectra taken of IYD (60 µM) in 10 mM potassium 
phosphate (pH 7.4) in the presence and absence of 300 µM MIT at 25 °C in a 0.1 cm 






Y157 and K178 form hydrogen bonds to the carboxylic acid of the substrate. 
Removing only one of these two contacts, as with Y157F, would still allow for an 
interaction with the carboxylic acid of the substrate. We can assume that K178 is 
sufficient for stabilizing this interaction. This is in comparison to E153 that forms 
hydrogen bonds with the amine on the substrate. E153 is the only amino acid that 
hydrogen bonds to this group. Therefore, in order to observe substrate binding, thus 
catalysis, the active site lid must contact both zwitterionic groups.  
These residues must be involved in orienting the substrate, stabilizing the 
active site lid and indirectly activating the FMN for catalysis.  Dissecting their role 
has been facilitated by expression of the deiodinase in E. coli for routine site-directed 
mutagenesis.  Perhaps a fine balance is maintained between dynamic and fixed states 
of the lid region. This active site lid is unique to IYD within its structural 
superfamily. These residues are defining factors to discriminate IYD from its 











Chapter 5: Expression of homologous IYD 
 
5.1 Introduction 
IYD is the only known mammalian member of the NADH oxidase/flavin 
reductase structural superfamily (19, 31). Other enzymes in the superfamily are 
bacterial flavoproteins that function as NADPH oxidases or flavin reductases (32, 
33). Until the crystal structure of IYD was solved, the enzymes in the structural 
superfamily were thought to belong to one of the two subclasses based on the primary 
structure of the active site lid domain. The active site lid domain of the bacterial 
enzymes is either between β2 and αE or after β5 while IYDs active site lid is αC to 
αDE (Figure 5.1). The location of the active site lid can distinguish between the three 
classes of enzymes in the NADPH oxidase/flavin reductase superfamily. IYD forms a 
third subclass of enzymes in this structural superfamily because the placement of its 
active site lid domain differs from the other two classes (31).  
IYD has a unique function of dehalogenation within the NADPH 
oxidase/flavin reductase superfamily. Not only does IYD deiodinate its native 
iodinated substrate but it dehalogenates bromo- and chlorotyrosines (26).  The 
enzyme with the most similar structure (very low RMSD of 3.1 Å) is the bacterial 
enzyme BluB (PDB ID: 2ISK). BluB catalyzes yet another type of reaction; the 
degradation of FMN to 5,6-dimethylbenzimidazole for the synthesis of Vitamin B12 
(34). The organization of the subclasses is further confirmed by the placement of the 
sequence of the active site lid of BluB and the difference in chemistry from the rest of 




αDE for the active site lid compared to that of NOX and FRP (Figure 5.1). Here, we 
have enzymes of different function with very similar structure characterized from two 
very distant organisms, mammals and bacteria.  
 
Figure 5.1 Secondary structure alignment of representative enzymes from the 
NADPH oxidase/flavin reductase superfamily. Protein Data Bank identifiers are as 
follows: IYD is 3GFD, BluB is 1ISL, NOX is NOX1, and FRP is 2BKJ. Figure 
adapted from Thomas, et. al. (31).  
 
 
Structural homology of enzymes and their relation to the respective sequences 
has been a major point of study. The overall structures of bacterial enzymes in the 
NADPH oxidase/flavin reductase superfamily are very similar despite the sequence 
location of the active site lid. Enzymes are classified by function through the Enzyme 
Commission (EC) and by structure through secondary structure classes. Enzyme 
functions range over a variety of structural classes and enzymes in the same EC 
family catalyze different reactions, as clearly evident by the NADPH oxidase/flavin 
reductase superfamily.  
The variation between structure and function occurs through two types of 
evolution: divergent and convergent. Divergent evolution is when a common ancestor 
yields superfamilies of enzymes that catalyze different reactions. Convergent 
evolution independently generates unrelated enzymes that catalyze the same type of 
chemical reaction. Within the structural superfamily, all of the enzymes belong to EC 




structural evolution. However, they are different subclasses within. Both NOX and 
FRP are in “acting on NADPH” subclass (1.6) and IYD is in a different subclass 
“acting on a halogen” (1.22) (64). As far as classifying enzymes, ID, the other 
dehalogenase found in thyroid cells, belongs to subclass 1.97, with an alternative 
function classification of “other” (64). ID, although it is a flavoprotein that acts on a 
halogen, it does not use its flavin directly for dehalogenation. Instead, it performs its 
deiodination through the use of selenocysteines, so it is not directly related to 
convergent evolution. ID and IYD dehalogenation reactions are not classified in the 
same subclass because they catalyze dehalogenation in different manner. 
IYD evolved from a structural superfamily of bacterial enzymes that are 
classified in the same enzyme class of reactions. In order to determine how 
dehalogenation activity evolved from its superfamily, we must bridge the gap 
between Eubacteria (bacteria) and Eukaryotes. The availability of DNA libraries 
allows us to search the sequence for a specific match based on DNA sequence or the 
respective translated protein sequence. The use of the National Center for 
Biotechnology Information (NCBI) Basic Local Alignment Search Tool (BLAST) 
(65) has greatly enhanced search capabilities. Currently, the BLAST database has 
sequencing data for about 200 organisms, almost a quarter of the available genome 
sequences are animals. The sequences deposited in NCBI are annotated by 
GNOMON to affiliate a structure and a function.  
A BLAST search of the mammalian IYD protein sequence results in 
approximately 30 homologous sequences from different organisms. Many of the 




more generally labeled as “nitroreductase” or “oxidoreductase” from the Conserved 
Domains Database (66). The BLAST output also indicates the putative FMN binding 
sites based on the sequence alignment. Many non-mammalian animals (Figure 5.2) 
have a homologous protein including: Vertebrate classes Osteichthyes and Aves are 
represented by Danio rerio (zebrafish) and Gallus gallus (chicken), respectively, 
Cnidaria are represented by Nematostella vectensis and Hydra magnipapillata (sea 
anemone and sea squirt, respectively), Echinodermata is represented by 
Strongylocentrotus purpurtus (sea urchin), Branchiostoma floridae in subphylum 
Cephalochordata (lancelet), Xenopus laevis or Xenopus tropicalis for Amphibia 
(frog), Arthropoda represented by Apis mellifera (honeybee), Drosophilia 
melengaster (fruit fly), and Tribolium castaneum (beetle), Nematoda represented by 
Caenorhabditis elegans (worm). The amino acid sequences of predicted IYD from 





Figure 5.2 Phylogenetic tree of metazoan (animal) life. Classes and Phyla in blue 
indicate animals where predicted or hypothetical iodotyrosine deiodinases have been 
identified. Deiodination is primary necessary in glands were thyroid hormones are 
found, specifically follicular thyroids and endostyles. Branches are not drawn to 
scale.  
 
Sequence alignments of predicted iodotyrosine deiodinase proteins indicate 
that eukaryotic organisms in different phyla may possess deiodinase activity (Figure 
5.3). There are four criteria to base this prediction: an N-terminal membrane domain, 
flavin binding residues, an active site lid in the same domain as mammalian IYD, and 
the substrate binding residues E153, Y157, and K178. Mammalian IYD, in its native 
form, has a membrane binding region (Figure 5.3, green box), which is known to be 
necessary for retaining the ability to be reduced by NADPH in vivo (18). IYD does 
not bind NADPH directly and prior to catalysis, FMN must be reduced. So this must 




residues (two blue boxes). Two flavin binding regions are located on opposite 
polypeptide chains, so dimerization is necessary for flavin binding. Specifically, 
threonine 235 in the mouse sequence directly hydrogen bonds with the N5 of FMN. 
This contact is constant within the subclass of the superfamily and is presumed to 
help stabilize the anionic semiquinone (67). The third criterion is the presence of 
sequence for the substrate-induced structure surrounding the active site that defines 
IYD from the rest of the proteins in the superfamily (red and light blue boxes). The 
homologous sequence must have sequence in the same region as IYD that the 
bacterial sequences lack. The third necessity is the presence of the three substrate 
binding residues, E153, Y157, and K178, defined in Chapter 4 (orange). These 
residues were found necessary for binding (thus catalysis) so they must also align to 
the mammalian IYD sequences.  Notice, as expected based on the active site lid 





Figure 5.3 Alignment of predicted IYD from organisms in different classes. The key 
domains from comparison are highlighted. The flavin binding regions are boxed in 
violet. The membrane binding domain is in green; substrate binding helices: Red; and 
the substrate induced structure loop is in light blue. The three residues highlighted in 
orange (E, Y and K) hydrogen bond to the substrate. Helical and β-sheet structural 




Representatives from each Phylum were chosen to test the hypothesis that the 
defined criteria are descriptive of deiodinase activity. Each of the organisms chosen 
has been well characterized and is used as model organisms to developmental 
biology. Starting closest to Mammalia, we chose sequences progressively farther 
away from known deiodinases. The Danio rerio (zebrafish) gene was chosen from the 
Class Osteichthyes. Zebrafish are known to have a thyroid and thyroid hormone (35), 
so it is an obvious first choice because it needs all the necessary machinery to 
produce thyroid hormone. The predicted IYD should in fact be iodotyrosine 
deiodinase. The second sequence chosen is from Branchiostoma floridae (lancelet) in 
the subphylum Cephalochordata.	  Lancelets have an endostyle that exhibits thyroid-
like activity and accumulates iodide (68). The next outward branch is another 
subphylum of Deuterostomia. There was evidence for a homologous sequence in 
Strongylocentrotus purpurtus (sea urchins), the subphylum Echinodermata, but the 
NCBI accession could not be confirmed. This subphylum was skipped and we 
proceeded to Protostomia and the subphylum Arthropoda. Four insects were found to 
have a sequence homologous to IYD. The sequence from Apis mellifera (honeybee) 
was ultimately chosen based on the least amount of excess sequence and a lack of 
additional cysteines. The final and furthest removed sequence was chosen from the 
organism Nematostella vectensis (sea anemone) in the phylum Cnidaria and the Class 
Anthosoa. Sea anemones live underwater in what is thought to be iodide rich 
environment. Iodide is highly water-soluble so it is less likely that an organism would 
need to harbor iodide in such a manner that would require a specific deiodination 




sequence in the N-terminus that may bind the membrane like the known mouse 
sequence. This can serve as a representative slightly deviated from the defined 
criteria. If some or all of the sequences retain deiodinase activity, we can then 
hypothesize where the evolution of a dehalogenase arose, from an otherwise NADPH 
oxidase/flavin reductase superfamily. The sequences in Figure 5.3 from the 
representative phyla were expressed and assayed for deiodinase activity. The genes 
were truncated to express the predicted soluble domain of the entire sequence.  
Furthermore, the reason that these organisms would need a deiodinase is investigated 
and presented through a developmental biology perspective.	  
 
5.2 Experimental 
5.2.1 Materials  
Genes from zebrafish (Accession: XM_691419), lancelet (Accession: 
XM_002237516), honeybee (Accession: XM_397179) and sea anemone (Accession: 
XM_001633119) were ordered from Blue Heron Biotechnology (Bothell, WA) or 
GenScript (Piscataway, NJ). Rosetta2 (DE3) Escherichia coli were purchased from 
Novagen (San Diego, CA).  pET28-SUMO was obtained with permissions from Dr. 
Christopher Lime. All other reagents were obtained at the highest grade available and 





5.2.2 IYD presence and Phylogenetic analyses  
The presence/absence of IYD and related proteins was determined by 
searching gene names in public databases and through species-specific BLAST 
searches. For the BLAST analysis, sequence similarity greater than 57% similarity 
and a specific hit to the NADPH oxidase/flavin reductase conserved domain (66) was 
considered significant. Protein sequences were extracted from NCBI and sequence 
identifiers can be found in Appendix C. Sequence alignments were performed using 
ClustalW (69). Transmembrane regions were predicted by TMHMM (70). Structure 
modeling was performed using SWISS-MODEL (71) and was allowed to search for 
the template or model based on PDB ID 3GFD.  
 
 
Expression of IYD from zebrafish, lancelet, honeybee, and sea anemone 
pET28-SUMO plasmids containing homologous IYD genes were transformed 
into Rosetta2 E. coli. One colony inoculated a 20 mL LB culture containing 
kanamycin and chloramphenicol, which was in turn used to inoculate 1 L LB with the 
same antibiotics. Cells were grown at 37 °C with shaking to an OD600 of 0.6. Protein 
expression was induced with 0.4 mM IPTG and allowed to shake at 18 °C for four 
hours. Cells were harvested by centrifugation for 5 minutes at 5000 x g and lysed by 
three rounds on a French press. Insoluble proteins were removed by centrifugation at 
40,000 x g for two hours.  




The soluble proteins were filtered (0.2 µm) and loaded on a HiTrap Ni+2 
chelating column. The column was washed with three column volumes of wash 
buffer (500 mM sodium chloride, 50 mM sodium phosphate (pH 8), 10 mM 
imidazole) and five column volumes of wash buffer with 70 mM imidazole. SUMO-
IYD was eluted with 250 mM imidazole in wash buffer. Fractions containing SUMO-
IYD were pooled, digested with Ulp1, and dialyzed against wash buffer containing 
0.1 mM dithiothreitol (DTT). IYD was re-loaded on a HiTrap Ni+2 chelating column 
and washed with three column volumes of wash buffer. Step wise elution of IYD and 
SUMO included 10 column volumes of wash buffer with 70 mM imidazole, 10 
column volumes of wash buffer with 100 mM imidazole, and 7 column volumes of 
wash buffer with 250 mM imidazole. Fractions containing IYD without SUMO were 
pooled and dialyzed against wash buffer containing 0.1 mM DTT. Upon removing the 
protein from dialysis, if the solution was cloudy with yellow precipitate, DTT was 
added to a final concentration of 1 mM to restore the protein to solution. 
Deiodination activity of IYD 
The discontinuous assay described in Chapter 3 was performed on purified 
IYD. Protein dependence was measured at 20 µM DIT for 30 minutes and time 
dependence of each protein was measured at 0.08 µM IYD at 20 µM DIT over one 
hour. Data was collected and fit to Michaelis-Menten equation as reported previously.  
5.3 Results and Discussion 
IYD homolog’s were found in metazoan species in the phyla of Vertebrata, 
Urochodata, Arthropoda, Nematoda, and Cnidaria. A complete list of NCBI accession 




organisms from each phyla were chose as individual representatives of a general 
branch of metazoans. Chordata are represented two Danio rerio (zebrafish) for 
Osteichthyes and Branchiostoma floridae (lancelet) for Cephalochordata, Arthropoda 
represented by Apis mellifera (honeybee), and Cnidaria are represented by 
Nematostella vectensis (sea anemone).  
 Sequences were aligned using ClustalW (69). TMHMM predicted that the 
genes from zebrafish, honeybee, and lancelet each have an N-terminal membrane 
anchor of approximately 25 amino acids. Although the gene from sea anemone has 
sequence that aligns to mouse IYD, TMHMM did not predict that this region is 
membrane bound. We had predicted that the N-terminal membrane domain is critical 
to defining these proteins as a deiodinase. The gene from sea anemone filled the 
remaining criteria and so it was used as an intermediate between the two subgroups of 
the superfamily. The proteins from these will be referred to as the first letter of the 
Genus and Species before IYD; drIYD represents the protein from the homologous 
sequence found in Danio rerio, etc. The abbreviation IYD(Δtm) refers to the 
truncated mouse protein sequence.  
 
5.3.1 Protein expression and purification 
Previously, we had expressed full length mammalian proteins in the HEK 293 
cell line and not encountered any folding problems (18). So, the full length sequences 
were ordered according to their native DNA sequence reported in NCBI (Table 2-1). 
The genes in pcDNA3.1 vector expressed in HEK 293 cells according to Western 




deiodinase activity. Recent advances in our lab suggested that we could express 
truncated IYD in E. coli through the use of an N-terminal SUMO fusion protein. 
The truncation length to remove the N-termianl membrane domain was 
directed by the information from the sequence alignment and the length of the 
predicted membrane domain from TMHMM. The truncation was made in 
approximately the same location compared to that of the known soluble expression 
sequence of mouse protein.  The actual amino acid lengths expressed of the specified 
locus from each organism are listed in Table 2-1. 
 
Table 2-1. Homologous IYD gene accession numbers and specific lengths of amino 
acids used for expression in E. coli.  
Species Protein NCBI Locus Amino Acids Expresseda 
Danio rerio drIYD(Δtm) XM_691419 42-297 
Branchiostoma floridae bfIYD(Δtm) XM_002237516 37-292 
Apis mellifera amIYD(Δtm) XM_397179 44-296 
Nematostella vectensis nvIYD XM_001633119 1-264 
aThe numbers refer to the amino acid number of the respective sequence. 
 
Truncated gene sequences were expressed in Rosetta 2 E. coli in the pET28-
SUMO vector. The fusion protein was found to be soluble and ranged from >10 to 
30% of the soluble proteins. The fusion protein was initially purified on a Ni+2 
chelating column and proteolysed from the SUMO fusion using Ulp1 during dialysis. 
SUMO and predicted IYDs were separated on a second pass through the Ni+2 column 
(Figure 5.4). IYD eluted as a yellow protein and was confirmed to have one mole of 
FMN per mole of protein. The homologous proteins bind flavin at the same molar 




the final dialysis. This is most likely due to the additional cysteines in the sequence. 
DTT would reduce these cysteines, creating an environment conducive to a more 
soluble protein.  
 
Figure 5.4 SDS-PAGE analysis of Ni+2 purified proteins expressed in E. coli. Proteins 
from different organisms are labeled by the first letter of the genus and species. Danio 
rerio: drIYD; Branchiostoma floridae: bfIYD; Apis mellifera: amIYD; Nemostella 
vectininas: nvIYD.  
 
5.3.2 Homologous sequences are IYD  
Purified proteins were tested for deiodinase activity based on the assay 
previously described. Each protein displayed Michaelis-Menten kinetic properties and 
was found to possess deiodinase activity! (Figure 5.5) The rates of deiodination of the 
truncated enzymes are very similar to that of mouse IYD(Δtm) (Table 5-2). The 
kcat/KM values for these homologous enzymes are all within error of the mouse 
enzymes previously studied without the N-terminal membrane anchor (40).  The 




efficiency indicating that dehalogenation of a mono or dihalogenated tyrosine could 
be the native substrate.  
 
Figure 5.5 Initial rates of DIT deiodination by deiodinases. Data points are an average 
of three trials and the error bars represent the standard deviation at each 
concentration. Kinetic constants were obtained by fitting to Michaelis-Menten 
kinetics using Origin 7.0.  
 
Since all of the predicted proteins possessed deiodinase activity with a similar 
rate, just one of these homologous proteins was tested for its affinity for the substrate. 
The zebrafish protein (drIYD(Δtm)) was the simplest to purify so it was used for 
equilibrium titration studies with MIT. Two independent titrations (Figure 5.6) were 
averaged and fit to a quadratic binding equation as previously described in Chapter 3 
(21).  drIYD(Δtm) binds MIT with 10 times lower affinity than mouse IYD(Δtm) ( 




mouse IYD(Δtm)DM for MIT (Chapter 3). IYD(Δtm)DM was previously used as a 
model for IYD(Δtm) because of its ability to be expressed as soluble protein in E. coli 
and its similarity to parent protein IYD(Δtm) expressed in Sf9 or P. pastoris. The five 
fold difference in binding affinity is relatively insignificant and we can assume that 
iodinated tyrosines are the native substrates for these homologous proteins.  
 
Table 5-2. Kinetic parameters of IYD(Δtm) from different species expressed in E. 
coli. 
Species kcat (min-1) KM (µM) kcat/KM (min-1 µM-1) 
Mus musculusa 6.9 ± 1.3 19 ± 3 0.36 ± 0.09 
Nematostella vectensis 6.1 ± 2.3 19 ± 16 0.32 ±  0.31 
Danio rerio 4.1 ± 0.2 29 ± 7 0.29 ± 0.08 
Branchiostoma floridae 7.2 ± 1.5 8 ± 1 0.53 ± 0.07 
Apis mellifera 8.2 ± 1.0 6 ± 3 1.2 ± 0.74 







Figure 5.6 Fluorescence quenching of FMN bound to drIYD(Δtm) by MIT. 
Fluorescence emission (λem 527 nm; λex 450 nm) was monitored during titration of 
MIT to a solution of drIYD(Δtm) (4.5 µM in 10 mM phosphate, pH 7.4). Data points 
of two trials and an average (black square) are plotted and error bars represent 
standard deviation.  
 
 
5.3.3 Structure modeling of homologous IYD 
The structure modeling of homologous proteins was completed to determine 
how the sequences would fit to the known structure of IYD. From this we can see if 
the sequence aligns well to the known structure and easily map the sequence 
differences. Protein sequences were entered in SWISS-MODEL to thread the 
sequence to a model structure from the Protein Data Bank. This can be done either by 
a user defined PDB ID or allowing the database to choose a PDB file. Each sequence 
was submitted using both methods and the outcome was the same. The mouse IYD 
crystal structure in complex with MIT (PDB ID 3GFD) was chosen as the user-




allowed to search for a model PDB, the same PDB ID (3GFD) was the result. 
Therefore, both the user-defined query and the open ended query resulted in the same 
theoretical structure. SWISS-MODEL reports a QMEAN z-score as an indication of 
goodness of fit for the provided sequence to the model. For the four sequences 
QMEAN z-scores were: -0.73 for sea anemone, -0.979 for zebrafish, -1.844 for 
lancelet, and -1.795 for honeybee.  The human sequence which has 90% sequence 
identity to the mouse sequence was reported with a QMEAN z-score of -0.83 
indicating that these z-scores are appropriate to use the predicted structure as a model.  
However, when the NOX bacterial sequence was threaded to the mouse IYD 3GFD 
structure, SWISS-MODEL reported a warning. A low QMEAN z-score (-5.29) was 
reported indicating that mouse IYD structure is a bad model to fit the NOX sequence. 
Similarly, when the zebrafish sequence was threaded to the PDB ID 1NOX, a similar 
warning arose from SWISS-MODEL. When the NOX sequence was used as input to 
SWISS-MODEL and allowed to search the database for an appropriate structure, the 
1NOX PDB was reported with a QMEAN z-score of 0.102. Thus, the program works 
because it chose the appropriate structure for the known sequence. When this protein 
from the same structural superfamily was threaded to the mouse IYD PDB a poor 
structure was constructed.  This is a good indication that the sequences chosen are in 
fact IYD sequences and not artifacts of the structural superfamily.  
There are no significant differences in the predicted structures of any of the 
four homologous proteins to the mouse structure.  We can see the overall fold of each 
of the sequences is very similar (Figure 5.7). Specific differences are mapped and 




have different functional groups than the mammalian sequence. For instance, a 
change from tyrosine to phenylalanine is considered a difference because of the loss 
of the hydroxyl group. A change from valine to leucine or isoleucine or any variation 
of those three is not considered a difference. The one carbon difference between 
glutamate and aspartate is not considered significant because the functional groups 
remain and in theory can make the same hydrogen bonding contacts. 
 
Figure 5.7 Structural alignment of backbone from SWISS-MODEL predicted 
structure of homologous IYD sequences and mouse IYD. Zebrafish drIYD is in 
green, honeybee am IYD is in blue, lancelet bfIYD is pink, sea anemone nvIYD is 










Figure 5.8 Modeling by SWISS-MODEL of homologous sequences to the mouse 
IYD crystal structure. Side chains in red represent non-conserved residues between 
the respective sequence and the mammalian sequence. To the right, each active site is 
highlighted. FMN and MIT are in yellow.  
 
The vast majority of the different amino acids are located on the surface of the 
protein. When we closely examine the active site we are able to see the pocket does 
not have any residues highlighted in red indicating that the active site is highly 
conserved (Figure 5.8, right). This is very important because it tells us that even with 
only 60% sequence identity, the interior of active site are nearly identical. This is a 
good comfirmation that deiodination is the native activity. 
The network of amino acids that form the active site lid are also conserved, 
evidenced by the structure we see in green in Figure 5.8 and the red box in the 
sequence alignment from Figure 5.3. Amino acids R100, N156, M161, R165, W165, 
D168, L169, K171, W176, L237 from one chain and V205, H206, Y207, and Y208 
from the other are highly conserved. These are the residues that form the tight 
network of hydrogen bonds to sequester the substrate from solution. These 
interactions are important in defining a protein as being a dehalogenase rather than 
the bacterial oxidoreductase.  Flavin binding location and the core α and β folds are 
the same across the structural superfamily but their active sites vary vastly.  The 
nitroreductases do not create a more shallow binding pocket for their substrates when 
compared to the dehalogenases in the same superfamily. Presence of these amino 
acids should be used in the future as defining criteria for dehalogenation.  
Initially, the presence of cysteines in the aligned sequence was used as criteria 
to discriminate between a deiodinase and a oxidoreductase (19). Since it is now 




ignored in this study. The lancelet sequence does not have cysteines at either location 
(mouse residues 217 and 239). Sea anemone and honeybee sequences have an 
additional cysteine replacing a serine at mouse residue 214. In the mouse (and 
human) sequence, this is a serine on the criss-crossing helix at the dimer interface. It 
faces towards the other chain and presumably forms a hydrogen bond with S214 on 
the opposite chain based on the proximity of the side chain.  On the sea anemone and 
honeybee sequences the cysteines may in theory form a disulfide bond in that close 
proximity. The two cysteines of the honeybee and sea anemone sequences can be 
seen at their respective dimer interfaces in Figure 5.8 (amIYD and nvIYD, 
respectively).  
It was originally thought that any sequence with additional cysteines would 
not be an ideal choice for expression in E. coli based on based on poor expression 
results described in Chapter 2. Upon purification, these two proteins would 
precipitate at 4 °C within three hours in wash buffer. However, after the addition of 
more DTT, the proteins would refold in a matter of minutes, as observed by the 
disappearance of yellow precipitate and the return of a clear rather than opaque 
solution. The addition of DTT leads us to believe that the cysteines are reduced in 
solution. Thus, they would not form the predicted disulfide bond at residue 214 and 
perhaps are forming similar hydrogen bonds to that expected from the mouse crystal 
structure.  
The homologous proteins from zebrafish, lancelet, honeybee, and sea 
anemone do in fact function as iodotyrosine deiodinases. The defining criteria were 




have a region defined as an active site lid, which was predicted by modeling to fold in 
the same manner as the mouse IYD sequence. Each homologous IYD bound 
equimolar flavin in a constructive conformation as indicated by deiodinase activity. 
An N-terminal membrane domain is not necessary for dithionite-dependent catalysis 
but will be necessary for facilitating reducing equivalents to FMN in vivo (72).  
Although we do not know the specific reductase that reduces the FMN bound to IYD, 
it is apparent that one must exist based on previous work (18, 38, 41). More 
interestingly, many of these organisms have a known requirement for iodide, 
specifically sea squirt, sea urchin, lancelet, zebrafish, and frog (5, 7, 35, 73, 74).  
Thyroid hormones, T3 and T4, have been discovered during metamorphosis in 
organisms without a follicular thyroid (75-77).  
There is good indication that halogenated tyrosines exist in the investigated 
organisms. All of these organisms go through metamorphosis during their 
development. Thyroid hormone has been known for years to influence 
metamorphosis. Almost 100 years ago, frogs were studied with and without a thyroid. 
Those without a thyroid remained as tadpoles and upon iodinated tyrosines fed in 
their diet, morphed into frogs (4). Frogs, although may seem distant, are not very 
different from mammals when you look at the broad scale of the animal kingdom. 
Frogs are still chordates, the same phylum as mammals, but are part of the Amphibia 
class. The Vertebrata subphylum, including the Class Osteichthyes (e.g. zebrafish), 
all have a follicular thyroid. The presence of a thyroid indicates that these animals 
would endogenously produce thyroid hormone and possess regulating machinery 




thyroid would need a pathway to recycle the uncoupled iodinated tyrosines so it isn’t 
so surprising that IYD is present.  Homologous IYD sequences were detected in 
organisms that have an endostyle, specifically the subphyla Urochorata (e.g. sea 
squirt) and Cephalochordata (e.g. lancelet). An endostyle is a region near the 
notochord that morphs into a thyroid in the most basic chordate, the lamprey (78).   
Thyroid hormone signaling pathway has been defined in lancelets and 
zebrafish (6, 35). The presence of thyroid peroxidase, thyroglobulin, a sodium iodide 
symporter, and thyroid stimulating hormone receptor indicate that lancelets, like the 
zebrafish chordates, endogenously produce thyroid hormone (6). Sea urchins have 
evidence of thyroid hormone related function, which leads us to believe that even 
though this sequence was not expressed, it most likely would have the deiodinase 
(79). The alternative to thyroid hormone production is uptake from the environment. 
Phytoplankton, a part of the diet for marine life, is a large source of iodide in marine 
environments and implicated in metamorphosis. There is evidence of thyroid 
hormone in mollusks that would be endogenously synthesized from iodide uptake 
(79). Contrast to using MIT for thyroid hormones, organisms might possess MIT for 
its antioxidant properties to scavenge radicals (80). This property would make 
iodotyrosines useful signaling molecules between cells (81) as they can insert 
themselves in lipid membranes when bound to other small molecules (72).  
Growth, morphological, and physiological stages of chordates have been 
explored with respect to a thyroid gland and its respective properties (6, 79, 82, 83). 
Authors have isolated the protein from bovine and porcine thyroids (36), performed 




This is the first study to express and purify homologous enzymes to test the 
hypothesis that proteins predicted to be deioidinases indeed function as deiodinases. 
We biochemically characterized each protein and confirm that the annotated sequence 
of a predicted or hypothetical protein is in fact a deiodinase. Looking back, it should 
not be so surprising that each of the sequences chosen are enzymes that retain 
deiodinase activity. But the question still remains as to where the shift occurred from 





Chapter 6: Conclusions 
 
IYD is a flavoprotein essential to a properly functioning thyroid. It forms a 
homodimer with two identical active sites that each bind FMN and is a member of the 
NADPH oxidase/flavin reductase structural superfamily. The location of the helical 
lid that folds to surround the active site separates proteins in this superfamily into 
three subclasses. This structural difference, in addition to its completely different 
function, places IYD in a separate subclass of the structural superfamily.  
IYD performs reductive dehalogenation to remove iodide from a mono or 
diiodinated tyrosine which are the byproducts of thyroid hormone synthesis. The 
protein is primarily found in the thyroid where iodide is harbored to make thyroid 
hormones. Thyroid hormones help regulate mammalian metabolism. Thyroid 
hormones are known to aid in development, specifically for organisms that undergo 
metamorphosis. These organisms have a thyroid or endostyle and may only have 
expression of IYD as larvae and not as adults. Additionally, the organisms without a 
thyroid (lancelet and sea anemone) have homologous sequences to the thyroid 
peroxidase, sodium iodide symporter, and transthreyatin. The honeybee genome only 
has a sequence homologous to the sodium iodide symporter. This may be a false 
positive and could be a symporter for other ions.  
Four organisms from different levels of the phylogenetic tree of life were 
chosen to represent respective phyla as we trace the activity of iodotyrosine 




criteria for choosing sequences was successful. However, this has yet to give us any 
information to dissect where the protein shifts from its structural superfamily of 
oxidreductases to a dehalogenase.  
Criteria were easily defined only after heterologous expression of IYD was 
successful. IYD was engineered to express a soluble protein in E. coli by use of 
fusion protein, two his-tags and mutation of two cysteines to alanines. This protein 
was found to be biochemically equivalent to the wild-type truncated protein 
expressed in HEK 293, Sf9, and Pichia pastoris (40). Expression in E. coli was 
critical to making mutations to study proteins. The cysteine mutant protein can be 
used as a model of the wild-type protein to create additional mutations to study 
substrate coordination. In the active conformation, substrate hydrogen bonds to three 
amino acids (E153, Y157, and K178) on the active site lid. E153 is necessary for 
proper binding of the substrate in the active site and thus disrupts catalysis. Mutation 
to Y157 decreased the affinity of the protein for MIT and increased enzymatic 
turnover implying a decrease in stability of the enzymes active complex. Information 
could not be reported on K178 due to improper folding in vivo. The active site lid, the 
presence of the three coordinating amino acids, flavin binding residues, and an N-
terminal hydrophobic sequence were the criteria chosen to define a deiodinase from 
the other members of the superfamily. Additionally, the network of amino acids 
protecting the active site from solvent that form the lid are conserved based on the 
sequences already known to have deiodinase activity. The presence of these should be 




A recent BLAST search resulted in identification of homologous sequences 
from CFB bacteria Haliscomenobacter hydrossis and the Crusteaca Daphnia pulex 
(water flea). The bacterial genome was published in June 2011 (85) and the water flea 
genome was published only months earlier in February 2011 (86). The sequence 
available from the bacterial genome is annotated as a nitroreductase while the water 
flea sequence is annotated as “iodotyrosine dehalogenase” on the NCBI. Based on the 
BLAST results using the predicted IYD from CFB bacteria, a phylogenetic tree was 









Figure 6.1 The phylogenetic tree based on BLAST results using the hypothetical IYD 





From this tree we can see that CFB bacteria are on a clade closest to known 
IYD sequences and farthest from other bacterial sequences. This is indicative that the 
protein may in fact be a deiodinase and not a nitroreductase, or at the very least, close 
to the branch point between the two. These sequences will be purchased and screened 
for deiodinase activity. Neither organism has sequence information as evidence of the 
other thyroid-like proteins (thyroid peroxidase, etc). Lacking other thyroid proteins 
could indicate that these proteins do not have deiodinase activity despite adhering to 
the specified criteria. It is also plausible that they do function as iodotyrosine 
deiodinases and serve an unknown physiological role.  With this additional 

































































































































































































































































































































































































































































































































































































































































































































B. Propagation of error 
 

























organism common name gene sequence protein sequence 
    
Homo sapien human NM_203395.2 NP_981932.1 
Rattus norvegicus norway rat NM_001025000  NP_001020171 
Sus scrofa pig NM_214416.1 NP_999581.1 
Mus musculus mouse NM_027391 NP_081667 
Canis lupus familiaris dog XM_856900   XP_533449 
Pan troglodyte chimpanzee XM_001135488 XP_001135488  
Macaca mulatta monkey XM_001098926 XP_001098926  
Ornithorhynchus 
anatinus platypus XP_001505946 XM_001505896 
Bos taurus wild boar NM_001102165.1 NP_001095635.1 
Gallus gallus red jungle fowl XP_419670 XP_419670      
Xenopus laevis frog NM_001093860 NP_001087329 
Gadus morhua atlantic cod ES470904        
Oncorhynchus mykiss rainbow trout  BX302875  
Danio rerio zebrafish XM_691419 XP_696511 
Branchiostoma floridae lancelet XM_002237516 XP_002237552.1 
Hydra magnipapillata hydra XM_002164492  XP_002164528  
Nematostella vectensis starlet sea anemone XP_001633169   XM_001633119     
Apis mellifera honey bee XM_397179 XM_397179 
Anopheles gambiae malaria mosquito XM_315442  XM_315442.4 
Drosophilia melengaster fruit fly NP_648433 NP_648433  
Aedes aegypti mosquito XP_001660302 XP_001660302 
Tribolium castaneum beetle XM_961277 XM_961277  
Caenorhabditis elegans worm NP_498712 NM_066311.2 
Haliscomenobacter 
hydrossis CFB bacteria NC_015510.1 YP_004447048.1 
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